https://curecurrent.com/trials/appalachian-partnership-to-reduce-disparities-aim-2-125007https://curecurrent.com/trials/auricular-vagus-nerve-stimulation-mechanisms-for-hiv-associated-peripheral-neuropathy-125008https://curecurrent.com/trials/testing-two-interventions-to-improve-health-outcomes-and-quality-of-life-among-rural-older-adults-living-with-hiv-125009https://curecurrent.com/trials/sleep-outcomes-and-multidimensional-sleep-assessment-a-randomized-trial-of-dolutegravir-vs-doravirine-based-antiretrovir-125010https://curecurrent.com/trials/a-phase-2-study-of-foscenvivint-in-liver-cirrhosis-patients-caused-by-hiv-hcv-co-infection-with-hemophilia-125011https://curecurrent.com/trials/a-study-to-evaluate-the-pharmacokinetics-safety-and-tolerability-of-a-new-formulation-of-cabotegravir-long-acting-admini-125012https://curecurrent.com/trials/therapy-adapted-for-high-risk-and-low-risk-hiv-associated-anal-cancer-125013https://curecurrent.com/trials/small-trial-of-alendronate-impact-on-the-reservoir-of-hiv-125014https://curecurrent.com/trials/a-simple-intervention-to-increase-persistence-on-prep-in-msm-to-improve-decision-making-125015https://curecurrent.com/trials/frailty-geriatric-syndromes-and-care-pathways-of-older-adults-living-with-hiv-in-west-africa-125016https://curecurrent.com/trials/effectiveness-of-zidovudine-vs-zidovudine-plus-alpha-interferon-vs-interferon-for-treatment-of-hiv-125017https://curecurrent.com/trials/imaging-and-biopsy-of-people-with-hiv-1-undergoing-analytic-treatment-interruption-125018https://curecurrent.com/trials/mycobacterial-and-opportunistic-infections-in-hiv-negative-thai-and-taiwanese-patients-associated-with-autoantibodies-to-125019https://curecurrent.com/trials/case-management-dyad-125020https://curecurrent.com/trials/trans-stair-implementing-an-evidence-based-trauma-treatment-with-community-led-prep-navigation-125021https://curecurrent.com/trials/feasibility-study-comparing-one-vs-two-probes-for-ta-among-cervical-cancer-screen-positive-wlwh-in-c1001p-cs5-rwanda-125022https://curecurrent.com/trials/safety-study-of-zinc-finger-nuclease-ccr5-modified-hematopoietic-stem-progenitor-cells-in-hiv-1-infected-patients-125023https://curecurrent.com/trials/effect-of-acute-alcohol-intoxication-on-neural-processes-during-decisions-to-engage-in-hiv-risk-behaviors-125024https://curecurrent.com/trials/screening-with-portable-x-rays-for-rapid-recognition-of-tb-125025https://curecurrent.com/trials/trial-to-evaluate-the-safety-and-immunogenicity-of-a-modified-vaccinia-ankara-mva-based-anti-cytomegalovirus-cmv-vaccine-125026https://curecurrent.com/trials/safety-and-immunogenicity-of-recombinant-varicella-zoster-virus-vaccine-in-people-with-hiv-who-have-a-cd4-count-less-tha-125027https://curecurrent.com/trials/a-study-to-evaluate-performance-usability-and-contrived-result-interpretation-of-truplex-hiv-hepb-syphilis-rapid-test-125028https://curecurrent.com/trials/quantitative-measurement-and-correlates-of-the-latent-hiv-reservoir-in-virally-suppressed-ugandans-125029https://curecurrent.com/trials/the-eswatini-prism-study-on-adolescents-living-with-hiv-125030https://curecurrent.com/trials/cash-transfers-to-pregnant-women-with-hiv-125031https://curecurrent.com/trials/study-of-voicing-my-choices-as-a-tool-for-advanced-care-planning-in-young-adults-with-cancer-125032https://curecurrent.com/trials/immunogenicity-of-the-9-valent-human-papillomavirus-recombinant-vaccine-in-people-with-idiopathic-cd4-t-cell-lymphocytop-125033https://curecurrent.com/trials/tissue-biopsy-and-imaging-studies-in-hiv-infected-patients-125034https://curecurrent.com/trials/t-cell-therapy-eb103-in-adults-with-relapsed-refractory-b-cell-non-hodgkin-s-lymphoma-nhl-125035https://curecurrent.com/trials/gene-therapy-and-combination-chemotherapy-in-treating-patients-with-aids-related-non-hodgkin-lymphoma-125036https://curecurrent.com/trials/immunotherapy-with-glatiramer-acetate-in-plwhiv-in-poor-immunological-responders-on-antiretroviral-therapy-125037https://curecurrent.com/trials/implementation-study-of-lenacapavir-pre-exposure-prophylaxis-for-hiv-prevention-125038https://curecurrent.com/trials/auricular-point-acupressure-for-pain-125039https://curecurrent.com/trials/precision-microbiota-interventions-for-senoreduction-trial-125040https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-effects-of-repeated-doses-of-3bnc117-ls-and-10-1074-ls-on-persistent-viral-reservoirs-125041https://curecurrent.com/trials/a-study-evaluating-implementation-strategies-for-the-delivery-of-apretude-for-black-cis-and-transgender-women-in-united-125042https://curecurrent.com/trials/a-study-to-evaluate-the-safety-and-antiviral-activity-of-two-human-monoclonal-antibodies-vrc07-523ls-and-pgt121-414-ls-d-125043https://curecurrent.com/trials/validation-of-self-testing-using-the-insti-multiplex-hiv1-2-syphilis-antibody-test-125044https://curecurrent.com/trials/social-contact-based-brief-video-interventions-to-reduce-stigma-and-improve-engagement-in-hiv-prevention-and-care-and-me-125045https://curecurrent.com/trials/immunologic-and-virologic-parameters-during-analytical-treatment-interruption-following-combination-bnab-therapy-during-125046https://curecurrent.com/trials/physical-activity-for-plwh-and-unhealthy-drinking-125047https://curecurrent.com/trials/a-study-to-evaluate-the-effectiveness-of-long-acting-la-cabotegravir-cab-rilpivirine-rpv-la-when-given-to-participants-w-125048https://curecurrent.com/trials/work2prevent-plus-structural-intervention-to-promote-hiv-care-in-black-sexual-minority-men-125049https://curecurrent.com/trials/innate-like-and-nk-signatures-in-chronic-treated-hiv-infection-instinct-hiv-125050https://curecurrent.com/trials/a-clinical-study-of-alimatravir-mk-8527-in-transgender-trans-and-gender-diverse-individuals-on-gender-affirming-hormone-125051https://curecurrent.com/trials/quitting-matters-human-immunodeficiency-virus-hybrid-trial-125052https://curecurrent.com/trials/a-reinforcement-intervention-for-increasing-hiv-testing-among-at-risk-women-125053https://curecurrent.com/trials/hiv-engagement-and-adolescent-depression-support-heads-up-125054https://curecurrent.com/trials/urine-hpv-testing-for-cervical-cancer-screening-among-women-living-with-hiv-in-south-africa-125055https://curecurrent.com/trials/b-palmz-for-tb-meningitis-125056https://curecurrent.com/trials/leveraging-infant-visit-prep-integration-task-shifting-to-improve-post-partum-hiv-prevention-in-malawi-125057https://curecurrent.com/trials/hiv-testing-in-community-health-center-dental-clinics-125058https://curecurrent.com/trials/india-hiv-cervca-project-125059https://curecurrent.com/trials/reducing-co-occurring-substance-use-and-hiv-risk-among-stimulant-using-men-at-high-risk-for-hiv-in-the-united-states-of-125060https://curecurrent.com/trials/shared-decision-making-to-treat-or-prevent-stop-hiv-in-criminal-legal-involved-populations-r33-125061https://curecurrent.com/trials/testing-a-mobile-health-application-to-improve-hiv-prevention-and-substance-use-treatment-among-women-involved-in-the-ca-125062https://curecurrent.com/trials/integrating-u-u-into-hiv-counseling-in-south-africa-intuit-2-0-125063https://curecurrent.com/trials/building-rapid-inpatient-delivery-of-art-to-generate-engagement-in-hiv-care-125064https://curecurrent.com/trials/early-metabolic-effects-of-antiretroviral-drugs-in-healthy-volunteers-a-phase-2-randomized-study-125065https://curecurrent.com/trials/a-study-to-investigate-cabotegravir-ultra-long-acting-cab-ula-plus-rilpivirine-ultra-long-acting-rpv-ula-in-adults-and-a-125066https://curecurrent.com/trials/optimizing-hiv-pre-exposure-prophylaxis-prep-among-women-who-use-drugs-in-tanzania-125067https://curecurrent.com/trials/specimen-collections-from-participants-with-hiv-infection-kshv-infection-viral-related-pre-malignant-lesions-and-cancer-125068https://curecurrent.com/trials/molecular-characterization-of-viral-associated-tumors-tumors-occurring-in-the-setting-of-hiv-or-other-immune-disorders-a-125069https://curecurrent.com/trials/a-study-to-investigate-the-use-of-vh3810109-with-or-without-fostemsavir-ftr-to-reduce-the-size-and-activity-of-the-viral-125070https://curecurrent.com/trials/leukapheresis-procedures-to-obtain-plasma-and-lymphocytes-for-research-studies-on-antiretroviral-naive-hiv-1-research-pa-125071https://curecurrent.com/trials/adapting-a-stress-management-intervention-to-reduce-cardiovascular-disease-risk-125072https://curecurrent.com/trials/viral-load-in-blood-and-lymph-tissues-in-people-living-with-hiv-125073https://curecurrent.com/trials/virotherapy-and-natural-history-study-of-khsv-associated-multricentric-castleman-s-disease-with-correlates-of-disease-ac-125074https://curecurrent.com/trials/phase-1-study-of-ch505-hiv-vaccine-nanoparticles-and-mrna-boosters-in-healthy-adults-125075https://curecurrent.com/trials/pharmacokinetic-study-of-long-acting-antiretrovirals-and-contraceptives-in-hiv-125076https://curecurrent.com/trials/integrating-tuberculosis-treatment-into-community-pharmacies-to-improve-tb-hiv-outcomes-in-uganda-125077https://curecurrent.com/trials/predictive-analytics-and-clinical-decision-support-to-improve-prep-prescribing-125078https://curecurrent.com/trials/hiv-and-alcohol-research-center-focused-on-polypharmacy-harp-pilot-2-2nd-harp-pilot-intervention-125079https://curecurrent.com/trials/automated-video-assisted-smoking-treatment-for-people-living-with-hiv-125080https://curecurrent.com/trials/daratumumab-for-relapsed-refractory-primary-effusion-lymphoma-plasmablastic-lymphoma-and-multicentric-castleman-disease-125081https://curecurrent.com/trials/the-smart-art-study-125082https://curecurrent.com/trials/supporting-health-and-empowerment-through-contingency-management-and-affect-regulation-125083https://curecurrent.com/trials/adapting-the-esteem-intervention-to-improve-mental-health-and-prep-uptake-among-men-at-risk-of-hiv-125084https://curecurrent.com/trials/proof-of-principle-study-of-pulse-dosing-of-il-15-to-deplete-the-reservoir-in-hiv-infected-people-125085https://curecurrent.com/trials/tissue-drug-levels-of-hiv-medications-125086https://curecurrent.com/trials/1morestep-an-intervention-to-increase-hiv-care-engagement-and-reduce-intimate-partner-violence-among-black-women-living-125087https://curecurrent.com/trials/thinking-and-memory-problems-in-people-with-hiv-125088https://curecurrent.com/trials/protecting-against-hiv-vaccine-misinformation-with-adolescent-girls-and-young-women-in-south-africa-125089https://curecurrent.com/trials/search-cab-la-dynamic-choice-hiv-prevention-study-extension-125090https://curecurrent.com/trials/targeted-therapies-for-immunological-non-responders-in-people-with-hiv-a-multicenter-clinical-study-125091https://curecurrent.com/trials/sustainability-and-precision-prevention-project-125092https://curecurrent.com/trials/feasibility-study-comparing-one-vs-two-probes-for-thermal-ablation-among-cervical-cancer-screen-positive-wlwh-in-c1001p-125093https://curecurrent.com/trials/validation-of-a-tuberculosis-treatment-decision-algorithm-in-hiv-infected-children-tb-speed-hiv-125094https://curecurrent.com/trials/feasibility-study-comparing-one-vs-two-probes-for-thermal-ablation-among-cervical-cancer-screen-positive-women-living-wi-125095https://curecurrent.com/trials/problems-with-immune-recovery-in-the-gut-tissue-125096https://curecurrent.com/trials/feasibility-study-comparing-use-of-one-or-two-probes-for-thermal-ablation-among-cervical-cancer-screen-positive-women-li-125097https://curecurrent.com/trials/study-of-gs-0415-and-how-it-works-in-people-with-hiv-125098https://curecurrent.com/trials/integrating-addiction-treatment-and-hiv-services-into-primary-care-clinics-in-ukraine-125099https://curecurrent.com/trials/choices-teen-randomized-controlled-trial-125100https://curecurrent.com/trials/behavioral-economic-intervention-to-improve-hiv-behaviors-in-sexual-minority-individuals-125101https://curecurrent.com/trials/smoking-cessation-medication-and-rewards-using-a-teamlet-to-treat-tobacco-use-disorder-smarttt-2-0-among-persons-with-hi-125102https://curecurrent.com/trials/leveraging-chatbot-to-improve-prep-in-the-southern-united-states-125103https://curecurrent.com/trials/prep4u-assessing-the-effectiveness-of-integrated-same-day-lenacapavir-initiation-and-follow-up-choice-on-prep-persistenc-125104https://curecurrent.com/trials/implementing-prep-for-women-who-inject-drugs-125105https://curecurrent.com/trials/paradoxical-tuberculosis-reactions-in-patients-without-hiv-infection-125106https://curecurrent.com/trials/el-camino-hiv-prevention-and-care-study-125107https://curecurrent.com/trials/natural-history-study-of-the-kshv-inflammatory-cytokine-syndrome-kics-125108https://curecurrent.com/trials/the-dart-deliver-02-study-125109https://curecurrent.com/trials/analysis-of-hiv-1-replication-during-antiretroviral-therapy-125110https://curecurrent.com/trials/studies-of-the-pathogenesis-of-hiv-infection-in-human-peripheral-blood-cells-and-or-body-fluids-in-people-living-with-an-125111https://curecurrent.com/trials/the-effect-of-murottal-quran-on-fatigue-severity-scale-and-shatri-sinulingga-psychosomatic-test-scores-in-patients-with-125112https://curecurrent.com/trials/leukapheresis-to-obtain-plasma-or-lymphocytes-for-studies-of-hiv-infected-patients-including-long-term-non-progressors-125113https://curecurrent.com/trials/adelante-a-randomized-controlled-trial-to-improve-engagement-in-care-for-latinos-with-hiv-125114https://curecurrent.com/trials/trial-of-allogeneic-reduced-intensity-hla-haploidentical-allogeneic-hematopoietic-cell-bone-marrow-transplantation-follo-125115https://curecurrent.com/trials/enhancing-communication-on-relationship-preservation-safer-conception-and-prep-to-promote-hiv-testing-in-uganda-125116https://curecurrent.com/trials/herpesviruses-reactivation-in-hiv-infected-women-initiating-art-hera-125117https://curecurrent.com/trials/rudi-kundini-pamoja-kundini-phase-i-125118https://curecurrent.com/trials/integrating-supports-to-promote-prep-for-black-adolescents-working-with-apps-atlanta-125119https://curecurrent.com/trials/a-seek-test-and-treat-intervention-to-reduce-chlamydia-trachomatis-disparities-125120https://curecurrent.com/trials/immuno-virological-evaluation-of-persons-living-with-hiv-plwh-125121https://curecurrent.com/trials/developing-a-chatbot-to-promote-hiv-testing-125122https://curecurrent.com/trials/integrating-supports-to-promote-prep-for-black-adolescents-working-with-apps-alabama-125123https://curecurrent.com/trials/implementing-depression-and-adherence-treatment-125124https://curecurrent.com/trials/precision-imaging-to-evaluate-kaposi-sarcoma-125125https://curecurrent.com/trials/city-wide-implementation-and-evaluation-of-the-b-ok-bottles-for-hiv-treatment-adherence-support-in-the-philadelphia-ryan-125126https://curecurrent.com/trials/the-tail-prep-study-125127https://curecurrent.com/trials/addressing-risk-through-community-treatment-for-infectious-disease-and-opioid-use-disorder-now-action-among-justice-invo-125128https://curecurrent.com/trials/using-telehealth-to-address-alcohol-misuse-in-hiv-care-125129https://curecurrent.com/trials/a-clinical-study-of-islatravir-and-ulonivirine-for-people-with-hiv-1-who-have-not-been-treated-before-mk-8591b-062-125130https://curecurrent.com/trials/2dr-versus-3dr-in-a-prospective-randomized-controlled-switch-trial-125131https://curecurrent.com/trials/a-multilevel-multiphase-optimization-strategy-for-prep-most-prep-125132https://curecurrent.com/trials/pharmacies-in-hiv-prevention-fellowship-fundamentals-and-sustainable-finances-125133https://curecurrent.com/trials/improving-hiv-adherence-care-for-key-populations-in-india-125134https://curecurrent.com/trials/safety-immunogenicity-of-426c-mod-core-c4b-vaccine-with-3m-052-af-alum-in-infants-perinatally-exposed-to-hiv-but-uninfec-125136https://curecurrent.com/trials/pilot-hiv-self-testing-and-self-collected-sti-testing-strategy-for-sex-worker-empowerment-study-125137https://curecurrent.com/trials/a-study-of-mk-8527-to-prevent-human-immunodeficiency-virus-type-1-hiv-1-mk-8527-010-125138https://curecurrent.com/trials/clinical-decision-support-for-prep-125139https://curecurrent.com/trials/prison-based-hiv-partner-notification-125140https://curecurrent.com/trials/evaluation-of-a-differentiated-point-of-care-active-case-finding-management-model-to-eliminate-mother-to-child-transmiss-125141https://curecurrent.com/trials/a-clinical-study-of-mk-8527-to-prevent-human-immunodeficiency-virus-type-1-hiv-1-mk-8527-011-125142https://curecurrent.com/trials/the-integrated-female-sexually-transmitted-infection-testing-for-hiv-epidemic-control-through-prep-in-step-study-125143https://curecurrent.com/trials/efficacy-safety-and-pharmacokinetics-of-dtg-with-rif-125144https://curecurrent.com/trials/a-long-term-follow-up-of-the-hiv-nat-cohort-125145https://curecurrent.com/trials/enhancing-cervical-cancer-screening-and-treatment-in-women-living-with-hiv-in-kenya-the-enhance-linkage-trial-125146https://curecurrent.com/trials/couples-motivational-interviewing-to-reduce-drug-use-and-hiv-risk-in-vulnerable-male-couples-125147https://curecurrent.com/trials/accurate-staging-of-immuno-virological-dynamics-during-acute-hiv-infection-125148https://curecurrent.com/trials/evaluating-the-efficacy-of-annual-chtc-retesting-among-male-couples-at-high-risk-of-hiv-infection-125149https://curecurrent.com/trials/platelets-target-the-circulating-hiv-reservoir-implications-for-immunological-failure-125150https://curecurrent.com/trials/improving-hiv-diagnosis-linkage-to-care-and-prevention-services-with-hiv-point-of-care-nucleic-acid-tests-125151https://curecurrent.com/trials/the-latitude-study-long-acting-therapy-to-improve-treatment-success-in-daily-life-125152https://curecurrent.com/trials/administration-of-venetoclax-to-promote-apoptosis-of-hiv-infected-cells-and-reduce-the-size-of-the-hiv-reservoir-among-p-125153https://curecurrent.com/trials/pomalidomide-and-nivolumab-in-people-with-virus-associated-malignancies-with-or-without-hiv-125154https://curecurrent.com/trials/the-gender-inclusive-sexuality-talks-program-125155https://curecurrent.com/trials/improving-prevention-systems-to-reduce-disparities-for-high-priority-populations-125156https://curecurrent.com/trials/this-study-evaluates-the-alpco-syphilis-t-and-syphilis-nt-clia-kits-for-detecting-syphilis-antibodies-in-serum-and-plasm-125157https://curecurrent.com/trials/apheresis-to-obtain-plasma-or-white-blood-cells-for-laboratory-studies-125158https://curecurrent.com/trials/life-steps-counseling-to-enhance-adherence-and-engagement-in-prep-care-125159https://curecurrent.com/trials/optimizing-medications-and-lung-health-in-people-with-hiv-through-pharmacist-led-proactive-e-consults-125160https://curecurrent.com/trials/project-yes-for-young-msm-living-with-hiv-in-vietnam-125161https://curecurrent.com/trials/prevail-viii-a-cohort-clinical-viral-and-immunologic-monitoring-study-of-people-living-with-retroviral-infection-in-libe-125162https://curecurrent.com/trials/improving-teleprep-initiation-and-retention-outcomes-in-the-us-the-mistr-study-125163https://curecurrent.com/trials/transmasculine-one-on-one-and-group-empowerment-for-targeted-hiv-reduction-125164https://curecurrent.com/trials/genetic-markers-for-focal-segmental-glomerulosclerosis-125165https://curecurrent.com/trials/tuberculosis-preventive-therapy-among-latent-tuberculosis-infection-in-hiv-infected-individuals-125166https://curecurrent.com/trials/community-based-model-for-delivery-of-antiretroviral-therapy-in-cambodia-125167https://curecurrent.com/trials/new-techniques-for-using-a-saline-wash-as-a-diagnostic-tool-for-pneumocystis-pneumonia-125168https://curecurrent.com/trials/a-remotely-delivered-tai-chi-qigong-intervention-for-older-people-living-with-hiv-125169https://curecurrent.com/trials/combacal-hiv-prevention-twics-125170https://curecurrent.com/trials/a-study-to-investigate-safety-tolerability-and-pharmacokinetics-of-vh5356136-in-adult-participants-without-hiv-125171https://curecurrent.com/trials/wellness-intervention-strategies-and-hiv-care-125172https://curecurrent.com/trials/health-outcomes-by-neighborhood-baltimore-125173https://curecurrent.com/trials/feasibility-of-positive-links-for-youth-care-engagement-intervention-125174https://curecurrent.com/trials/improving-physical-ability-and-cellular-senescence-elimination-in-hiv-125175https://curecurrent.com/trials/cascade-2002-protect-study-probiotics-to-treat-anal-precancer-trial-125176https://curecurrent.com/trials/expanding-the-potential-of-couples-hiv-testing-adjunct-modules-to-reduce-drug-use-among-vulnerable-male-couples-125177https://curecurrent.com/trials/bnabs-and-anti-pd-1-in-hiv-125178https://curecurrent.com/trials/a-study-to-investigate-pharmacokinetics-pk-safety-and-tolerability-of-vh4367310-in-healthy-adult-participants-125179https://curecurrent.com/trials/qdiss-stud-qd-isentress-as-switch-strategy-in-virologically-suppressed-hiv-1-infected-patient-125180https://curecurrent.com/trials/headache-and-hormone-use-among-transgender-population-in-thailand-a-cross-sectional-online-study-125181https://curecurrent.com/trials/buprenorphine-integration-research-and-community-health-125182https://curecurrent.com/trials/a-clinical-study-of-the-hcmv-tb-vaccine-candidate-vir-1778-in-healthy-adults-125183https://curecurrent.com/trials/ighid-12230-an-implementation-trial-of-an-experiential-brief-alcohol-intervention-for-hiv-prevention-125184https://curecurrent.com/trials/nine-valent-hpv-vaccine-to-prevent-persistent-oral-hpv-infection-in-men-living-with-hiv-125185https://curecurrent.com/trials/a-trial-to-evaluate-the-safety-and-tolerability-of-dv700p-rna-and-dv701b1-1-rna-immunization-in-combination-with-antiret-125186https://curecurrent.com/trials/private-sector-access-to-testing-for-health-sustainability-125187https://curecurrent.com/trials/a-phase-2b-study-evaluating-vh4011499-capsid-inhibitor-long-acting-injectable-plus-cabotegravir-in-treatment-na-ve-adult-125188https://curecurrent.com/trials/prospective-clinical-performance-evaluation-of-the-in-vitro-diagnostics-medical-device-magia-ibc-for-the-combined-screen-125189https://curecurrent.com/trials/dolutegravir-lamivudine-dual-therapy-for-art-na-ve-people-with-hiv-and-tb-receiving-rifampin-based-tb-treatment-125190https://curecurrent.com/trials/people-living-with-hiv-oral-and-oropharyngeal-cancer-and-health-equity-125191https://curecurrent.com/trials/observational-pharmaco-epidemiology-research-analysis-125192https://curecurrent.com/trials/safety-study-of-mucocept-cvn-125193https://curecurrent.com/trials/project-shield-2-0-police-education-to-support-public-health-in-kentucky-125194https://curecurrent.com/trials/chronic-widespread-pain-in-hiv-novel-mechanisms-and-therapeutics-125195https://curecurrent.com/trials/renew-shcs-safety-and-immunogenicity-of-a-recombinant-hiv-env-protein-vaccine-in-arv-treated-adults-living-with-hiv-in-t-125196https://curecurrent.com/trials/pride-iii-prison-interventions-and-hiv-prevention-collaboration-125197https://curecurrent.com/trials/tenofovir-exposures-in-advanced-kidney-disease-study-125198https://curecurrent.com/trials/evaluation-of-semaglutide-in-adults-with-cocaine-use-disorder-with-and-without-hiv-125199https://curecurrent.com/trials/adaptation-of-an-intervention-addressing-barriers-to-prep-use-among-pregnant-women-in-zimbabwe-125200https://curecurrent.com/trials/the-tatelo-plus-study-125201https://curecurrent.com/trials/peru-decentralized-hiv-care-125202https://curecurrent.com/trials/evaluation-of-the-integration-of-ag-rdts-for-covid-19-in-mnch-hiv-and-tb-services-in-cameroon-and-kenya-125203https://curecurrent.com/trials/a-behavioral-mhealth-intervention-for-people-with-hiv-with-anxiety-and-depression-125204https://curecurrent.com/trials/the-kabeho-study-kigali-antiretroviral-and-breastfeeding-assessment-for-the-elimination-of-hiv-125205https://curecurrent.com/trials/a-savings-intervention-to-reduce-men-s-engagement-in-hiv-risk-behaviors-125206https://curecurrent.com/trials/reducing-stigma-in-people-who-inject-drugs-pwid-with-hiv-using-a-rapid-start-antiretroviral-therapy-intervention-art-125207https://curecurrent.com/trials/evaluation-of-advanced-hiv-disease-differentiated-care-model-in-malawi-125208https://curecurrent.com/trials/mobile-phone-technology-for-prevention-of-mother-to-child-transmission-of-hiv-acceptability-effectiveness-and-cost-kenya-125209https://curecurrent.com/trials/tele-harm-reduction-125210https://curecurrent.com/trials/early-empiric-anti-mycobacterium-tuberculosis-therapy-for-sepsis-in-sub-saharan-africa-125211https://curecurrent.com/trials/very-early-intensive-treatment-of-infants-living-with-hiv-to-achieve-hiv-remission-125212https://curecurrent.com/trials/a-study-to-provide-continued-access-to-study-drug-to-children-and-adolescents-who-have-completed-clinical-studies-involv-125213https://curecurrent.com/trials/a-phase-ii-trial-to-assess-extended-safety-and-tolerability-of-subcutaneous-cap256v2ls-and-vrc07-523ls-in-hiv-negative-w-125214https://curecurrent.com/trials/walk-in-therapy-in-low-barrier-primary-care-125215https://curecurrent.com/trials/characteristics-and-outcomes-of-patients-who-received-etravirine-and-or-darunavir-125216https://curecurrent.com/trials/juntas-adelante-a-peer-coaching-intervention-to-promote-chemoprophylaxis-for-hiv-prevention-among-latina-transgender-wom-125217https://curecurrent.com/trials/liver-transplantation-from-donors-with-hiv-impact-on-opportunistic-infections-cancer-and-long-term-outcomes-expanding-ho-125218https://curecurrent.com/trials/lamivudine-dolutegravir-in-virologically-suppressed-subjects-with-expected-or-confirmed-resistance-to-lamivudine-125219https://curecurrent.com/trials/south-africa-smoking-cessation-and-engagement-in-hiv-tb-care-care-125220https://curecurrent.com/trials/intervention-development-for-syndemics-among-pwh-in-sa-125221https://curecurrent.com/trials/development-and-evaluation-of-a-virtual-reality-tool-for-at-risk-trauma-exposed-young-people-125222https://curecurrent.com/trials/pregnant-and-parenting-teens-living-with-hiv-in-lusaka-zambia-125223https://curecurrent.com/trials/scope-observational-study-of-the-consequences-of-the-protease-inhibitor-era-125224https://curecurrent.com/trials/single-session-narrative-therapy-study-125225https://curecurrent.com/trials/a-pilot-study-of-an-online-hiv-stigma-training-for-nursing-students-in-iran-125226https://curecurrent.com/trials/developing-mhealth-to-promote-prep-use-among-thai-young-vulnerable-adolescents-and-emerging-adults-125227https://curecurrent.com/trials/selection-of-a-protective-t-cell-based-hiv-1-fiv-vaccine-125228https://curecurrent.com/trials/rv630-approach-to-control-hiv-with-immune-enhancement-and-vaccination-achiev-125229https://curecurrent.com/trials/leveraging-video-logs-as-a-bridge-to-pre-exposure-prophylaxis-prep-with-tailored-messaging-to-black-women-and-their-heal-125230https://curecurrent.com/trials/cytotoxic-t-lymphocytes-in-treating-patients-with-malignancies-with-bk-and-or-jc-virus-125231https://curecurrent.com/trials/integrating-prep-decision-making-into-counseling-in-sexual-and-reproductive-health-clinics-125232https://curecurrent.com/trials/positivelinks-for-youth-pl4y-for-texas-125233https://curecurrent.com/trials/optimizing-tobacco-use-treatment-for-plwha-125234https://curecurrent.com/trials/testing-the-efficacy-and-mechanisms-of-an-adapted-resilience-building-intervention-in-people-aging-with-hiv-125235https://curecurrent.com/trials/project-neuroartemis-125236https://curecurrent.com/trials/reinitiation-of-antiretroviral-therapy-using-oral-bictegravir-emtricitabine-and-tenofovir-alafenamide-125237https://curecurrent.com/trials/hope-in-action-prospective-multicenter-clinical-trial-of-deceased-hivd-kidney-transplants-for-hiv-recipients-125238https://curecurrent.com/trials/combating-hiv-stigma-in-healthcare-settings-a-standardized-patient-approach-125239https://curecurrent.com/trials/optimizing-care-for-cryptococcal-antigenemia-evaluation-of-short-course-fluconazole-and-art-timing-among-crag-persons-wi-125240https://curecurrent.com/trials/dynamic-decision-support-for-integrating-prep-in-clinics-for-young-people-in-alabama-and-botswana-125241https://curecurrent.com/trials/a-clinical-study-to-evaluate-the-safety-and-immunogenicity-of-a-higher-dose-of-the-study-vaccine-vir-1388-in-hcmv-seropo-125242https://curecurrent.com/trials/hiv-transmission-in-the-era-of-scaling-up-antiretroviral-therapy-in-ethiopia-125243https://curecurrent.com/trials/testing-a-community-friendly-risk-reduction-intervention-for-injection-drug-users-125244https://curecurrent.com/trials/optimal-intervention-to-full-viral-suppression-text-me-alexis-125245https://curecurrent.com/trials/hpv-infection-sexually-transmitted-infections-and-anal-dysplasia-in-the-transgender-population-125246https://curecurrent.com/trials/hotspot-study-implement-and-evaluate-the-prep-pre-exposure-prophylaxis-implementation-strategy-125247https://curecurrent.com/trials/evaluation-of-safety-immunogenicity-and-efficacy-of-a-triple-immune-regimen-in-adults-initiated-on-art-during-acute-hiv-125248https://curecurrent.com/trials/polypharmacy-on-healthy-aging-in-people-living-with-hiv-over-the-age-of-75-125249https://curecurrent.com/trials/efficacy-acceptability-and-safety-of-event-driven-hiv-prep-using-taf-ftc-in-msm-in-thailand-and-france-125250https://curecurrent.com/trials/clinic-vs-clinic-community-outreach-hpv-self-collection-to-increase-cervical-screening-in-women-living-with-hiv-125251https://curecurrent.com/trials/gene-therapy-after-frontline-chemotherapy-in-treating-patients-with-aids-related-non-hodgkin-lymphoma-125252https://curecurrent.com/trials/high-vs-standard-dose-rifampicin-for-effusive-tuberculous-pericarditis-125253https://curecurrent.com/trials/safety-and-immunogenicity-of-hpv-vaccine-in-hiv-infected-125254https://curecurrent.com/trials/prevail-viiia-evaluation-of-latent-tuberculosis-infection-screening-methods-in-people-living-with-retroviral-infection-i-125255https://curecurrent.com/trials/optimizing-prep-uptake-for-african-american-women-in-the-south-by-empowering-women-to-make-informed-hiv-prevention-and-s-125256https://curecurrent.com/trials/a-clinical-trial-investigating-the-safety-and-biological-activity-of-the-antibody-bnt351-in-adults-living-without-and-wi-125257https://curecurrent.com/trials/role-of-cbd-in-improving-alexithymia-125258https://curecurrent.com/trials/a-study-of-safety-and-drug-levels-of-epgt121v1-ls-pgdm1400ls-and-vrc07-523ls-in-adult-participants-without-hiv-1-125259https://curecurrent.com/trials/tuberculosis-sentinel-research-network-tb-srn-125260https://curecurrent.com/trials/expedited-partner-therapy-and-the-hiv-prevention-cascade-125261https://curecurrent.com/trials/natural-history-study-of-kaposi-sarcoma-125262https://curecurrent.com/trials/c-3002-enhancing-cervical-cancer-screening-access-and-follow-up-care-at-cascade-clinical-sites-in-the-united-states-125263https://curecurrent.com/trials/share-project-define-125264https://curecurrent.com/trials/same-day-antiretroviral-therapy-as-a-behavioral-design-intervention-to-reduce-stigma-in-key-affected-populations-125265https://curecurrent.com/trials/thailand-hiv-and-stigma-reduction-study-125266https://curecurrent.com/trials/p3-trial-estimating-the-impact-of-a-multilevel-multicomponent-intervention-to-increase-uptake-of-hiv-testing-and-biomedi-125267https://curecurrent.com/trials/zambia-healthy-choices-project-for-emerging-adults-living-with-hiv-125268https://curecurrent.com/trials/alhiv-smartphone-game-study-125269https://curecurrent.com/trials/improving-the-reach-effectiveness-of-smoking-cessation-services-targeted-to-veterans-living-with-hiv-125270https://curecurrent.com/trials/khanya-ekhaya-a-home-based-intervention-125271https://curecurrent.com/trials/liver-fibrosis-in-hiv-infected-patients-with-elevated-liver-enzymes-on-antiretroviral-therapy-125272https://curecurrent.com/trials/social-media-as-a-risk-tool-for-hiv-prevention-needs-125273https://curecurrent.com/trials/telemedicine-for-unhealthy-alcohol-use-in-persons-living-with-hiv-using-ceta-125274https://curecurrent.com/trials/harmonized-healing-personalized-music-interventions-to-address-chronic-pain-in-people-living-with-hiv-125275https://curecurrent.com/trials/spotting-syphilis-a-dual-point-of-care-syphilis-screening-initiative-in-a-low-resource-healthcare-setting-125276https://curecurrent.com/trials/five-point-initiative-a-bundled-implementation-strategy-to-address-the-hiv-epidemic-in-black-communities-125277https://curecurrent.com/trials/new-approaches-for-the-diagnosis-of-lymphoma-and-multicentric-castleman-disease-125278https://curecurrent.com/trials/hiv-and-alcohol-research-center-focused-on-polypharmacy-harp-pilot-1-125279https://curecurrent.com/trials/an-adaptive-platform-trial-for-evaluation-of-novel-treatment-regimens-in-children-and-adolescents-with-hiv-in-africa-125280https://curecurrent.com/trials/study-to-assess-efficacy-and-safety-of-m72-as01e-4-mycobacterium-tuberculosis-mtb-vaccine-in-adolescents-and-adults-125281https://curecurrent.com/trials/pilot-study-to-evaluate-the-decentralization-of-patient-care-among-people-with-hiv-in-out-of-hospital-settings-125282https://curecurrent.com/trials/prevalence-and-incidence-of-lassa-virus-infection-in-southern-mali-125283https://curecurrent.com/trials/pomalidomide-in-combination-with-liposomal-doxorubicin-in-people-with-advanced-or-refractory-kaposi-sarcoma-125284https://curecurrent.com/trials/a-global-record-of-patients-with-anal-squamous-cell-carcinoma-with-and-without-hiv-infection-125285https://curecurrent.com/trials/combinatorial-therapy-to-induce-an-hiv-remission-125286https://curecurrent.com/trials/a-roll-over-study-with-rilpivirine-for-human-immunodeficiency-virus-type-1-hiv-1-infected-participants-who-participated-125287https://curecurrent.com/trials/a-randomized-trial-of-impact-a-coping-intervention-for-hiv-infected-women-with-sexual-trauma-in-south-africa-125288https://curecurrent.com/trials/study-of-lenacapavir-as-a-once-yearly-injection-for-hiv-pre-exposure-prophylaxis-prep-125289https://curecurrent.com/trials/using-prep-doing-it-for-ourselves-125290https://curecurrent.com/trials/cabotegravir-rilpivirine-antiretroviral-therapy-in-pregnancy-125291https://curecurrent.com/trials/cd4-car-zfn-modified-t-cells-in-hiv-therapy-125292https://curecurrent.com/trials/evaluating-the-impact-of-using-the-b-ok-bottles-for-hiv-and-art-literacy-in-south-africa-125293https://curecurrent.com/trials/new-york-city-observational-study-of-mpox-immunity-125294https://curecurrent.com/trials/the-prevalence-of-oral-hpv-infection-and-oral-lesions-in-people-living-with-hiv-125295https://curecurrent.com/trials/kulindana-community-friendly-delivery-and-monitoring-of-tpt-to-improve-uptake-and-reduce-tb-transmission-125296https://curecurrent.com/trials/adjuvant-5-fluorouracil-following-thermal-ablation-to-improve-hpv-treatment-outcomes-in-women-with-hiv-in-kenya-125297https://curecurrent.com/trials/clinical-and-immunologic-monitoring-of-patients-with-known-or-suspected-hiv-infection-125298https://curecurrent.com/trials/joining-under-connected-networks-to-optimize-salud-health-juntos-125299https://curecurrent.com/trials/microbiome-metabolites-and-alcohol-in-hiv-to-reduce-cvd-rct-125300https://curecurrent.com/trials/identifying-challenges-to-healthy-aging-in-persons-with-human-immunodeficiency-virus-hiv-age-50-and-older-125301https://curecurrent.com/trials/swabs-in-screening-for-hpv-swish-125302https://curecurrent.com/trials/pharmacokinetic-properties-of-antiretroviral-and-anti-tuberculosis-drugs-during-pregnancy-and-postpartum-125303https://curecurrent.com/trials/strengthening-guidance-health-empowerment-125304https://curecurrent.com/trials/screening-strategies-among-high-risk-populations-for-anal-cancer-125305https://curecurrent.com/trials/safety-tolerability-and-efficacy-of-il-15-superagonist-n-803-with-and-without-combination-broadly-neutralizing-antibodie-125306https://curecurrent.com/trials/study-of-bictegravir-emtricitabine-tenofovir-alafenamide-in-newborns-exposed-to-hiv-125307https://curecurrent.com/trials/champion-combining-hiv-and-meth-prevention-and-treatment-interventions-optimized-for-hiv-negative-msm-125308https://curecurrent.com/trials/prep-pod-ivr-tdf-ftc-placebo-ivr-28-day-crossover-study-125309https://curecurrent.com/trials/enhancing-prep-uptake-and-retention-among-latine-tgw-and-gbm-in-the-south-using-long-acting-injectable-prep-125310https://curecurrent.com/trials/va-video-connect-in-hiv-care-125311https://curecurrent.com/trials/notre-optimizing-long-acting-pre-exposure-prophylaxis-and-medications-for-opioid-use-disorder-interventions-in-carceral-125312https://curecurrent.com/trials/an-mhealth-intervention-to-improve-outcomes-for-women-with-hiv-aids-125313https://curecurrent.com/trials/pomalidomide-and-dose-adjusted-epoch-rituximab-for-hiv-associated-lymphomas-125314https://curecurrent.com/trials/assessment-of-bone-mineral-density-in-people-living-with-hiv-and-kshv-associated-malignancies-a-retrospective-longitudin-125315https://curecurrent.com/trials/an-adaptive-multi-arm-trial-to-improve-clinical-outcomes-among-children-recovering-from-complicated-sam-125316https://curecurrent.com/trials/recombinant-glycosylated-human-interleukin-7-cyt107-for-the-treatment-of-kaposi-sarcoma-in-participants-with-hiv-and-imm-125317https://curecurrent.com/trials/abemaciclib-in-patients-with-hiv-associated-and-hiv-negative-kaposi-sarcoma-125318https://curecurrent.com/trials/genistein-for-the-reduction-of-adverse-cardiovascular-events-grace-125319https://curecurrent.com/trials/natural-history-of-kshv-associated-multicentric-castleman-s-disease-125320https://curecurrent.com/trials/pds01adc-monotherapy-and-in-combination-with-m7824-in-advanced-kaposi-sarcoma-125321https://curecurrent.com/trials/effect-of-pcsk9-inhibition-on-cardiovascular-risk-in-treated-hiv-infection-epic-hiv-study-125322https://curecurrent.com/trials/nurse-led-prep-initiation-among-incarcerated-individuals-125323https://curecurrent.com/trials/phase-ii-study-of-pacritinib-in-kaposi-sarcoma-herpesvirus-kshv-associated-multicentric-castleman-disease-and-kshv-assoc-125324https://curecurrent.com/trials/a-systems-analysis-and-improvement-approach-for-optimizing-hiv-service-delivery-in-syringe-services-programs-125325https://curecurrent.com/trials/measuring-adverse-pregnancy-and-newborn-congenital-outcomes-125326https://curecurrent.com/trials/enhancing-hiv-prevention-and-reducing-alcohol-use-among-people-receiving-sti-care-in-lilongwe-malawi-125327https://curecurrent.com/trials/screening-algorithms-for-cervical-and-anal-high-grade-squamous-intraepithelial-lesions-in-people-with-hiv-in-mexico-and-125328https://curecurrent.com/trials/expanding-hope-liver-125329https://curecurrent.com/trials/a-study-of-vrc07-523ls-pgt121-414-ls-and-pgdm1400ls-broadly-neutralizing-monoclonal-antibodies-given-intravenously-in-ad-125330https://curecurrent.com/trials/a-clinical-trial-to-look-at-the-safety-and-immune-responses-of-the-rna-based-vaccine-bnt168-in-adults-living-with-or-wit-125331https://curecurrent.com/trials/acceptability-and-feasibility-of-combination-treatment-for-cervical-precancer-among-south-african-women-living-with-hiv-125332https://curecurrent.com/trials/attachment-inhibitor-comparison-in-heavily-treatment-experienced-patients-125333https://curecurrent.com/trials/first-in-human-study-of-tlc-art-101-actu-2001-125334https://curecurrent.com/trials/early-neutralizing-antibodies-in-infants-living-with-hiv-to-enhance-their-life-125335https://curecurrent.com/trials/anal-high-risk-hpv-hsil-and-microbiome-among-hispanic-peoples-living-with-hiv-plwh-125336https://curecurrent.com/trials/early-neutralizing-antibodies-in-infants-living-with-hiv-to-enhance-their-life-2-125337https://curecurrent.com/trials/cd4-cell-count-at-antiretroviral-therapy-initiation-or-re-initiation-125338https://curecurrent.com/trials/making-art-work-among-brazilian-youth-125339https://curecurrent.com/trials/ambassaddors-for-health-study-125340https://curecurrent.com/trials/the-welcome-incoming-neighbor-win-community-trial-125341https://curecurrent.com/trials/uncpm-22322-adaption-of-the-transition-of-care-model-for-post-discharge-hiv-ncd-care-in-lilongwe-malawi-mlatho-125342https://curecurrent.com/trials/mobilizing-social-network-resources-for-hiv-care-support-125343https://curecurrent.com/trials/infectious-disease-id-testing-outreach-in-carceral-hubs-125344https://curecurrent.com/trials/multi-interventional-approaches-to-mitigate-hiv-reservoirs-for-the-sustained-hiv-remission-without-antiretrovirals-125345https://curecurrent.com/trials/a-study-of-daily-rifapentine-combined-with-isoniazid-1hp-for-tuberculosis-prevention-in-children-less-than-13-years-of-a-125346https://curecurrent.com/trials/a-trial-of-stratified-patient-centered-treatment-regimens-for-active-tb-spectra-tb-125347https://curecurrent.com/trials/siri-checklist-an-integrated-hospital-model-to-optimize-hiv-prevention-in-persons-who-inject-drugs-125348https://curecurrent.com/trials/assessing-the-prep-care-cascade-among-black-men-and-transwomen-in-the-southeastern-us-125349https://curecurrent.com/trials/online-cohort-of-sexual-and-gender-minorities-evaluating-digital-interventions-to-improve-hiv-pre-exposure-prophylaxis-a-125350https://curecurrent.com/trials/supporting-the-national-expansion-of-hpv-based-cervical-cancer-screening-in-tanzania-among-women-living-with-hiv-125351https://curecurrent.com/trials/project-space-testing-daily-text-messages-to-reduce-alcohol-use-and-hiv-risk-behavior-125352https://curecurrent.com/trials/cascade-testing-for-safety-and-immune-effects-of-pds0101-an-anti-hpv-therapy-among-people-living-with-hiv-125353https://curecurrent.com/trials/a-trial-testing-a-two-way-sms-platform-to-recognize-and-prevent-wasting-among-hiv-infected-and-hiv-exposed-uninfected-ch-125354https://curecurrent.com/trials/prep-soccer-a-program-for-pharmacy-chains-to-increase-prep-awareness-and-access-among-men-125355https://curecurrent.com/trials/sv2a-tspo-pet-imaging-measures-to-reveal-mechanisms-of-hiv-neuropathogenesis-during-antiretroviral-therapy-125356https://curecurrent.com/trials/positive-peers-intervention-clinical-trial-125357https://curecurrent.com/trials/effects-of-vagal-dysfunction-on-gastrointestinal-and-inflammatory-pathways-in-hiv-125358https://curecurrent.com/trials/evaluation-of-a-novel-optical-microscope-with-a-deep-depth-of-field-deepdof-to-provide-histologic-quality-images-on-cerv-125359https://curecurrent.com/trials/my-self-sampling-for-hpv-awareness-results-and-empowerment-125360https://curecurrent.com/trials/safety-of-anal-curcumin-125361https://curecurrent.com/trials/use-of-acu-d1-in-hpv-associated-vulvar-and-perianal-lesions-in-people-with-hiv-125362https://curecurrent.com/trials/detection-of-specific-metabolic-signatures-by-nuclear-magnetic-resonance-or-metabolomic-nmr-in-correlation-with-markers-125363https://curecurrent.com/trials/kentucky-outreach-service-kiosk-kyosk-reducing-hiv-hcv-and-overdose-risk-125364https://curecurrent.com/trials/a-clinical-trial-of-combination-hiv-specific-broadly-neutralizing-monoclonal-antibodies-combined-with-art-initiation-dur-125365https://curecurrent.com/trials/bedaquiline-roll-out-evidence-in-contacts-and-people-living-with-hiv-to-prevent-tb-125366https://curecurrent.com/trials/the-effects-of-chiropractic-care-on-inflammation-and-quality-of-life-in-people-living-with-hiv-125367https://curecurrent.com/trials/baricitinib-curative-repression-of-hiv-1-125368https://curecurrent.com/trials/reset-for-the-treatment-of-stimulant-use-in-hiv-clinics-care-optimization-supporting-treatment-adherence-costa-125369https://curecurrent.com/trials/short-term-effects-of-methamphetamine-on-residual-latent-hiv-disease-study-125370https://curecurrent.com/trials/pausing-antiretroviral-treatment-under-structured-evaluation-125371https://curecurrent.com/trials/study-of-lenacapavir-and-emtricitabine-tenofovir-disoproxil-fumarate-f-tdf-in-prevention-of-hiv-in-cisgender-women-in-th-125372https://curecurrent.com/trials/screen2prevent-s2p-125373https://curecurrent.com/trials/testing-a-real-time-electronic-antiretroviral-adherence-monitoring-intervention-125374https://curecurrent.com/trials/the-effect-of-antacids-and-multivitamins-on-raltegravir-125375https://curecurrent.com/trials/safety-and-immunogenicity-of-vpm1002-vaccination-or-bcg-revaccination-against-tb-in-pre-adolescents-living-with-and-with-125376https://curecurrent.com/trials/a-continued-access-study-for-participants-transitioning-from-viiv-healthcare-sponsored-or-viiv-healthcare-collaborative-125377https://curecurrent.com/trials/use-of-a-screening-tool-to-describe-hiv-related-cancer-burden-and-patient-characteristics-in-the-amc-125378https://curecurrent.com/trials/rudi-kundini-pamoja-kundini-125379https://curecurrent.com/trials/a-patient-oriented-research-mentoring-program-in-tobacco-dependence-and-implementation-science-research-125380https://curecurrent.com/trials/study-of-the-pharmacokinetics-and-safety-of-glecaprevir-pibrentasvir-initiated-in-pregnancy-in-women-with-hepatitis-c-wi-125381https://curecurrent.com/trials/promoting-hiv-risk-reduction-among-people-who-inject-drugs-a-stepped-care-approach-using-contingency-management-with-pre-125382https://curecurrent.com/trials/tolerability-safety-efficacy-of-argon-plasma-coagulation-to-treat-anal-intraepithelial-neoplasia-in-hiv-positive-men-125383https://curecurrent.com/trials/study-of-lenacapavir-teropavimab-and-zinlirvimab-versus-cabotegravir-and-rilpivirine-in-virologically-suppressed-adults-125384https://curecurrent.com/trials/phase-ib-iia-clinical-study-of-acc017-tablets-125385https://curecurrent.com/trials/evaluate-the-safety-immunologic-and-virologic-responses-of-donor-derived-dd-hiv-specific-t-cells-hst-in-hiv-infected-ind-125386https://curecurrent.com/trials/streamlining-telehealth-for-expanded-prep-utilization-through-community-partnerships-125387https://curecurrent.com/trials/rapid-hiv-hep-c-and-syphilis-screening-in-a-rural-street-medicine-clinic-125388https://curecurrent.com/trials/gwan-enjoy-life-a-peer-supported-mental-health-mentoring-intervention-to-improve-engagement-in-care-among-sexual-minorit-125389https://curecurrent.com/trials/bridge-to-belonging-peer-led-intervention-to-reduce-loneliness-and-depression-among-older-gay-and-bisexual-men-125390https://curecurrent.com/trials/ending-tobacco-use-through-interactive-tailored-messaging-for-cambodian-people-living-with-hiv-aids-125391https://curecurrent.com/trials/study-of-lenacapavir-and-emtricitabine-tenofovir-disoproxil-fumarate-f-tdf-for-prevention-of-hiv-in-people-who-inject-dr-125392https://curecurrent.com/trials/amc-120-glofitamab-plus-chemoimmunotherapy-in-newly-diagnosed-hiv-associated-large-b-cell-lymphoma-the-glofit-rchop-stud-125393https://curecurrent.com/trials/clinic-level-implementation-of-mhealth-to-improve-hiv-viral-suppression-for-patients-with-substance-use-disorders-125394https://curecurrent.com/trials/in-us-276-1340-pre-exposure-prophylaxis-to-prevent-hiv-acquisition-in-us-women-a-demonstration-project-125395https://curecurrent.com/trials/optimizing-care-delivery-to-support-reengagement-in-plwh-returning-to-hiv-care-after-treatment-lapses-in-zambia-125396https://curecurrent.com/trials/mpata-yathu-trial-for-young-women-in-zambia-125397https://curecurrent.com/trials/feasibility-acceptability-and-preliminary-efficacy-of-an-hiv-prevention-intervention-for-older-black-women-125398https://curecurrent.com/trials/reducing-stigma-and-building-employability-skills-for-young-people-with-hiv-in-zambia-125399https://curecurrent.com/trials/ketamine-assisted-recovery-for-methamphetamine-use-disorder-hiv-125400https://curecurrent.com/trials/effect-of-extra-virgin-olive-oil-consumption-on-the-occurrence-of-cardiovascular-events-in-population-living-with-hiv-125401https://curecurrent.com/trials/implementation-science-to-enhance-hiv-testing-services-during-emergency-care-in-kenya-125402https://curecurrent.com/trials/psilocybin-therapy-for-methamphetamine-use-disorder-and-hiv-125403https://curecurrent.com/trials/enhanced-mentor-mother-strategy-for-pregnant-and-postpartum-women-living-with-hiv-125404https://curecurrent.com/trials/stimulant-and-polysubstance-use-inflammation-and-sex-effects-on-myocardial-disease-in-hiv-125405https://curecurrent.com/trials/high-intensity-exercise-to-combat-vascular-and-cognitive-dysfunction-in-adults-with-hiv-125406https://curecurrent.com/trials/ibrutinib-rituximab-etoposide-prednisone-vincristine-sulfate-cyclophosphamide-and-doxorubicin-hydrochloride-in-treating-125407https://curecurrent.com/trials/differentiated-care-for-improved-health-systems-efficiency-and-health-outcomes-in-zambia-125408https://curecurrent.com/trials/implementation-and-assessment-of-a-medication-therapy-management-program-in-hiv-patients-at-high-risk-of-adverse-drug-ev-125409https://curecurrent.com/trials/person-centered-approaches-to-viremia-connection-rapport-and-engagement-study-125410https://curecurrent.com/trials/first-time-in-human-study-of-long-acting-vh4524184-formulations-125411https://curecurrent.com/trials/sustaining-innovative-tools-to-expand-youth-friendly-hiv-self-testing-125412https://curecurrent.com/trials/robot-assisted-rehabilitation-after-hiv-associated-stroke-botswana-125413https://curecurrent.com/trials/bioequivalence-study-of-adc118-tablets-in-healthy-chinese-volunteers-under-fasting-conditions-125414https://curecurrent.com/trials/optimization-of-a-behavioral-intervention-to-increase-physical-activity-in-older-adults-living-with-hiv-125415https://curecurrent.com/trials/adaptation-and-evaluation-of-an-intersectional-stigma-reduction-intervention-to-increase-hiv-care-engagement-among-women-125416https://curecurrent.com/trials/pre-exposure-prophylaxis-study-of-lenacapavir-and-emtricitabine-tenofovir-alafenamide-in-adolescent-girls-and-young-wome-125417https://curecurrent.com/trials/assessing-pharmacy-technician-educational-training-for-the-provision-of-over-the-counter-hearing-aids-in-rural-alabama-a-125418https://curecurrent.com/trials/study-among-people-living-with-hiv-and-their-health-professionals-of-associated-factors-of-resilience-to-self-stigma-125419https://curecurrent.com/trials/blood-markers-of-inflammation-blood-clotting-and-blood-vessel-function-in-hiv-infected-adults-125420https://curecurrent.com/trials/project-i-test-implementing-hiv-testing-in-opioid-treatment-programs-125421https://curecurrent.com/trials/tu-washindi-rct-adolescent-girls-in-kenya-taking-control-of-their-health-125422https://curecurrent.com/trials/combination-intervention-to-enhance-treatment-engagement-and-viral-suppression-among-sexual-and-gender-minority-youth-in-125423https://curecurrent.com/trials/transcranial-magnetic-stimulation-for-methamphetamine-use-disorder-in-plwh-125424https://curecurrent.com/trials/clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-the-v2-apex-directed-immunogens-dv201p-rna-and-dv202b1-rna-i-125425https://curecurrent.com/trials/wiseapp-for-spanish-speakers-living-with-hiv-125426https://curecurrent.com/trials/hiv-1-virologic-suppression-with-tmb-365-and-tmb-380-antibodies-study-125427https://curecurrent.com/trials/skills-to-empower-affirmative-men-125428https://curecurrent.com/trials/a-study-to-evaluate-jl18008-in-subject-with-hiv-immunological-non-responders-125429https://curecurrent.com/trials/comparisons-of-treatment-responses-of-early-syphilis-to-benzathine-penicillin-g-with-or-without-doxycycline-125430https://curecurrent.com/trials/the-path-study-cognitive-and-inflammation-targeted-gut-brain-interventions-in-alcohol-probiotics-alcohol-transcutaneous-125431https://curecurrent.com/trials/big-chicago-a-trial-of-basic-income-guarantee-for-young-people-living-with-hiv-125432https://curecurrent.com/trials/bringing-medicines-for-hiv-prevention-to-a-family-planning-clinic-125433https://curecurrent.com/trials/safety-and-tolerability-of-metformin-in-people-with-tuberculosis-tb-and-human-immunodeficiency-virus-hiv-125434https://curecurrent.com/trials/population-effectiveness-of-dolutegravir-implementation-in-sub-saharan-africa-125435https://curecurrent.com/trials/a-study-to-evaluate-the-safety-tolerability-and-pharmacokinetics-of-a-single-suspension-injection-of-investigational-cap-125436https://curecurrent.com/trials/surveillance-assessment-and-detection-of-influenza-associated-respiratory-infections-in-hiv-positive-and-negative-indivi-125437https://curecurrent.com/trials/evaluating-gardasil-hpv-vaccine-humoral-and-cellular-immune-responses-in-people-with-and-without-hiv-125438https://curecurrent.com/trials/ultra-short-course-bedaquiline-clofazimine-pyrazinamide-and-delamanid-versus-standard-therapy-for-drug-susceptible-tuber-125439https://curecurrent.com/trials/improving-management-of-recipients-of-care-with-hiv-viremia-to-optimize-viral-suppression-in-zambia-a-process-and-outcom-125440https://curecurrent.com/trials/accelerated-art-initiation-for-pwhiv-who-are-out-of-care-125441https://curecurrent.com/trials/dasatinib-for-hiv-1-reservoir-reduction-125442https://curecurrent.com/trials/prep-pre-exposure-prophylaxis-stigma-and-women-ethnodrama-pilot-phase-125443https://curecurrent.com/trials/acceptability-quality-of-care-patient-satisfaction-and-cost-effectiveness-of-monitoring-provided-by-nurses-or-physicians-125444https://curecurrent.com/trials/a-clinical-trial-of-mk-8527-and-rifampin-in-adult-participants-with-latent-tuberculosis-infection-mk-8527-019-125445https://curecurrent.com/trials/healthmpowerment-korea-pilot-testing-the-cultural-adaptation-of-a-digital-hiv-intervention-for-men-who-have-sex-with-men-125446https://curecurrent.com/trials/epoch-and-rituximab-to-treat-non-hodgkin-s-lymphoma-in-patients-with-hiv-infection-125447https://curecurrent.com/trials/community-popular-opinion-leader-intervention-for-hiv-prevention-uptake-in-rural-south-africa-125448https://curecurrent.com/trials/hiv-prevention-peer-navigation-for-justice-involved-women-125449https://curecurrent.com/trials/hispanic-men-building-respect-education-and-safety-hombres-manteniendo-respeto-educacion-y-seguridad-125450https://curecurrent.com/trials/secondary-cervical-cancer-prevention-of-vulnerable-women-with-hpv-and-hiv-co-infection-in-india-125451https://curecurrent.com/trials/providing-access-to-the-visual-environment-125452https://curecurrent.com/trials/are-louisiana-pharmacists-prepared-implementing-training-and-an-active-prep-pre-exposure-prophylaxis-prescribing-surveil-125453https://curecurrent.com/trials/the-happy-older-latinos-are-active-hola-health-promotion-study-in-hiv-infected-latino-men-125454https://curecurrent.com/trials/the-opens-trial-offering-women-prep-aim-1-125455https://curecurrent.com/trials/evaluating-the-efficacy-and-safety-of-dolutegravir-containing-versus-efavirenz-containing-antiretroviral-therapy-regimen-125456https://curecurrent.com/trials/increasing-prep-use-in-high-risk-social-networks-of-african-american-msm-in-underserved-low-risk-cities-125457https://curecurrent.com/trials/safety-and-efficacy-of-rituximab-for-treatment-of-multicentric-castleman-disease-in-malawi-125458https://curecurrent.com/trials/metabolic-liver-disease-in-newly-diagnosed-people-living-with-hiv-mashiv-tr-125459https://curecurrent.com/trials/tshireletso-safety-efficacy-and-feasibility-of-cabotegravir-la-prep-in-a-breastfeeding-population-in-botswana-125460https://curecurrent.com/trials/dolutegravir-pharmacokinetics-among-hiv-tb-coinfected-children-receiving-standard-and-high-dose-rifampicin-125461https://curecurrent.com/trials/thiphisa-new-pathways-to-prevention-from-community-tb-screening-in-south-africa-125462https://curecurrent.com/trials/long-term-follow-up-of-long-acting-cabotegravir-cab-la-for-prep-pre-exposure-prophylaxis-in-participants-at-risk-of-acqu-125463https://curecurrent.com/trials/dolutegravir-pharmacokinetics-during-weekly-rifapentine-isoniazid-for-tb-prevention-125464https://curecurrent.com/trials/optimizing-treatment-of-co-occurring-smoking-and-unhealthy-alcohol-use-among-pwh-in-nairobi-kenya-125465https://curecurrent.com/trials/smoking-cessation-program-for-lao-people-with-hiv-125466https://curecurrent.com/trials/study-to-evaluate-the-efficacy-safety-and-tolerability-of-long-acting-intramuscular-cabotegravir-and-rilpivirine-for-mai-125467https://curecurrent.com/trials/a-study-to-evaluate-the-use-of-resmetirom-in-participants-with-masld-and-hiv-125468https://curecurrent.com/trials/piloting-a-biomarker-augmented-alcohol-screening-brief-intervention-and-referral-to-treatment-sbirt-program-among-hiv-af-125469https://curecurrent.com/trials/prep-pre-exposure-prophylaxis-stigma-and-women-ethnodrama-pre-test-phase-125470https://curecurrent.com/trials/a-study-to-investigate-the-virologic-efficacy-and-safety-of-vh3810109-cabotegravir-compared-to-standard-of-care-soc-in-m-125471https://curecurrent.com/trials/syv-a-mental-health-intervention-to-improve-hiv-outcomes-in-tanzanian-youth-125472https://curecurrent.com/trials/healthy-lifestyles-a-home-based-physical-activity-intervention-in-persons-living-with-hiv-125473https://curecurrent.com/trials/impact-of-hiv-1-and-aging-on-mucosal-vaccine-responses-125474https://curecurrent.com/trials/community-health-workers-and-mhealth-to-improve-viral-suppression-plus-champs-125475https://curecurrent.com/trials/pnf-rct-to-decrease-alcohol-use-and-increase-hiv-prevention-125476https://curecurrent.com/trials/telehealth-for-pain-and-unhealthy-drinking-among-plwh-125477https://curecurrent.com/trials/vaginal-estradiol-vs-moisturizer-to-improve-postmenopausal-vaginal-aging-symptoms-and-the-microbiome-in-women-living-wit-125478https://curecurrent.com/trials/digital-prep-micro-intervention-for-pwud-in-kazakhstan-125479https://curecurrent.com/trials/national-rapid-tlc-testing-and-linkage-to-care-125480https://curecurrent.com/trials/identifying-and-addressing-barriers-to-retention-in-the-cervical-cancer-treatment-cascade-among-women-with-hiv-in-south-125481https://curecurrent.com/trials/virtual-reality-vr-self-hypnosis-software-125482https://curecurrent.com/trials/a-prospective-and-retrospective-observational-study-of-multidrug-resistant-patient-outcomes-with-and-without-ibalizumab-125483https://curecurrent.com/trials/rise-reducing-cancer-and-hiv-stigma-through-empowerment-125484https://curecurrent.com/trials/people-place-impacts-on-substance-use-and-hiv-outcomes-in-los-angeles-125485https://curecurrent.com/trials/optimization-of-antiretroviral-therapy-in-patients-with-aids-related-lymphoma-125486https://curecurrent.com/trials/efficacy-and-safety-of-high-dose-liposomal-amphotericin-b-for-disseminated-histoplasmosis-in-aids-125487https://curecurrent.com/trials/platform-trial-for-cryptococcal-meningitis-platform-cm-125488https://curecurrent.com/trials/e-hero-ending-the-hiv-epidemic-in-rural-oklahoma-125489https://curecurrent.com/trials/maps-prep-van-study-125490https://curecurrent.com/trials/safety-and-immunogenicity-of-clade-c-alvac-and-gp120-hiv-vaccine-125491https://curecurrent.com/trials/implementation-of-cab-rpv-la-for-people-with-hiv-in-non-metropolitan-areas-125492https://curecurrent.com/trials/analyses-of-newly-diagnosed-hiv-infection-in-hong-kong-125493https://curecurrent.com/trials/hiv-std-risk-and-prep-implementation-messaging-among-gay-bisexual-and-other-men-who-have-sex-with-men-125494https://curecurrent.com/trials/tuberculosis-clinical-trials-consortium-study-35-125495https://curecurrent.com/trials/the-ganchero-intervention-for-migrant-people-who-inject-drugs-from-puerto-rico-in-new-york-city-125496https://curecurrent.com/trials/safety-and-virologic-effect-of-a-human-monoclonal-antibody-vrc01-administered-intravenously-to-adults-during-early-acute-125497https://curecurrent.com/trials/a-phase-2b-study-evaluating-oral-vh4524184-regimens-in-treatment-na-ve-persons-with-hiv-1-innovate-study-125498https://curecurrent.com/trials/advanced-hiv-re-engagement-in-care-125499https://curecurrent.com/trials/evaluation-of-conditional-cash-transfers-to-increase-retention-in-pmtct-services-in-akwa-ibom-state-nigeria-125500https://curecurrent.com/trials/multi-product-prep-delivery-to-young-women-seeking-reproductive-health-services-and-coverage-of-hiv-prevention-125501https://curecurrent.com/trials/optimising-metabolic-management-for-people-with-human-immunodeficiency-virus-hiv-on-integrase-based-antiretroviral-thera-125502https://curecurrent.com/trials/pharmacy-based-provision-of-pre-exposure-prophylaxis-prep-for-adolescent-girls-and-young-women-in-tanzania-125503https://curecurrent.com/trials/targeted-universal-tb-testing-with-simultaneous-tpt-prescribing-among-people-living-with-hiv-in-south-africa-125504https://curecurrent.com/trials/homelink2-reducing-posthospitalization-mortality-through-structured-home-care-and-nutritional-support-125505https://curecurrent.com/trials/smartsteps-a-context-aware-prep-adherence-intervention-for-individuals-with-substance-use-disorder-125506https://curecurrent.com/trials/implementation-of-collaborative-care-for-depression-in-va-hiv-clinics-125507https://curecurrent.com/trials/pharmacokinetics-and-safety-of-double-dose-dolutegravir-when-used-with-rifapentine-for-hiv-associated-tuberculosis-125508https://curecurrent.com/trials/alcohol-and-heat-of-the-moment-sexual-decision-making-125509https://curecurrent.com/trials/the-women-s-screening-and-self-testing-program-prometa-study-125510https://curecurrent.com/trials/hope-in-action-trial-of-hiv-deceased-donor-liver-transplants-for-hiv-recipients-125511https://curecurrent.com/trials/efavirenz-efv-intensification-125512https://curecurrent.com/trials/efficacy-and-safety-of-the-acc017-based-antiretroviral-regimen-in-treatment-experienced-adults-with-hiv-1-harboring-non-125513https://curecurrent.com/trials/antiretroviral-adherence-evaluation-in-hiv-pregnant-and-postpartum-women-125514https://curecurrent.com/trials/efficacy-and-safety-of-acc017-tablets-compared-with-dolutegravir-sodium-tablets-in-treatment-na-ve-adults-with-human-imm-125515https://curecurrent.com/trials/care-disengagement-prevention-in-plwh-in-indonesia-125516https://curecurrent.com/trials/tfh-dysfunction-in-hiv-and-aging-125517https://curecurrent.com/trials/tenofovir-emtricitabine-and-efavirenz-late-switch-to-a-single-pill-patients-opinion-survey-125518https://curecurrent.com/trials/clinical-study-of-sti-screening-to-prevent-adverse-birth-and-new-born-outcomes-philani-ndiphile-125519https://curecurrent.com/trials/immediate-initiation-of-antiretroviral-therapy-during-hyperacute-hiv-infection-125520https://curecurrent.com/trials/hiv-disclosure-and-medication-adherence-a-pilot-study-125521https://curecurrent.com/trials/stop-shared-decision-making-to-treat-or-prevent-hiv-in-justice-populations-125522https://curecurrent.com/trials/reducing-psychological-barriers-to-prep-persistence-among-pregnant-and-postpartum-women-in-cape-town-south-africa-125523https://curecurrent.com/trials/the-learn-study-for-cvd-prevention-125524https://curecurrent.com/trials/this-trial-aims-to-evaluate-the-effect-of-two-hiv-stigma-reduction-interventions-at-the-health-facility-level-and-the-in-125525https://curecurrent.com/trials/strengthening-informed-consent-for-authentic-participation-in-perinatal-hiv-research-125526https://curecurrent.com/trials/developing-an-hiv-disclosure-intervention-for-men-in-uganda-125527https://curecurrent.com/trials/colchicine-to-reduce-coronary-artery-inflammation-in-people-with-hiv-125528https://curecurrent.com/trials/betterinfo-on-women-s-prep-choices-and-outcomes-in-malawi-125529https://curecurrent.com/trials/vitamin-d3-supplementation-in-patients-with-hiv-effects-on-interleukin-6-levels-and-cd4-counts-125530https://curecurrent.com/trials/intervention-to-improve-parent-communication-about-sexuality-125531https://curecurrent.com/trials/the-trans-led-care-study-125532https://curecurrent.com/trials/optimizing-pre-exposure-prophylaxis-prep-among-latino-men-who-have-sex-with-men-msm-in-puerto-rico-125533https://curecurrent.com/trials/a-trial-to-evaluate-an-hiv-envelope-trimer-n332-gt5-gp140-adjuvanted-with-smnp-in-adult-participants-without-hiv-125534https://curecurrent.com/trials/the-outreach-and-prevention-at-alcohol-venues-in-east-africa-study-opal-east-africa-aim-2-opal-aim-2-125535https://curecurrent.com/trials/long-term-real-world-evidence-study-to-evaluate-effectiveness-persistence-adherence-safety-and-tolerability-of-long-acti-125536https://curecurrent.com/trials/tmp-smx-for-non-hiv-pcp-a-prospective-multicenter-study-125537https://curecurrent.com/trials/incentives-and-reminders-to-improve-long-term-medication-adherence-inmind-125538https://curecurrent.com/trials/a-study-evaluating-the-pharmacokinetics-efficacy-safety-and-tolerability-of-cabenuva-125539https://curecurrent.com/trials/study-of-a-group-b-streptococcus-vaccine-in-pregnant-women-living-with-hiv-and-in-pregnant-women-who-do-not-have-hiv-125540https://curecurrent.com/trials/enhancing-smoking-cessation-for-african-american-people-everywhere-125541https://curecurrent.com/trials/stepping-stones-and-creating-futures-plus-pilot-125542https://curecurrent.com/trials/combatting-hiv-or-other-stis-early-choose-125543https://curecurrent.com/trials/cabotegravir-hormone-pk-pd-interactions-for-hiv-prevention-125544https://curecurrent.com/trials/lung-health-and-the-microbiome-among-adults-in-botswana-the-go-hema-cohort-125545https://curecurrent.com/trials/fuyang-jiedu-granules-plus-antiretroviral-therapy-for-hiv-immune-non-responders-with-spleen-kidney-yang-deficiency-125546https://curecurrent.com/trials/mindfulness-intervention-for-individuals-with-hiv-and-chronic-pain-125547https://curecurrent.com/trials/poc-hiv-testing-and-early-dtg-use-for-infants-125548https://curecurrent.com/trials/qiling-yiqi-tablets-plus-antiretroviral-therapy-for-hiv-immune-non-responders-with-lung-spleen-qi-deficiency-125549https://curecurrent.com/trials/group-antenatal-care-effectiveness-and-contextual-factors-linked-to-implementation-success-in-malawi-125550https://curecurrent.com/trials/a-study-to-investigate-the-safety-and-pk-of-vh4770359-in-healthy-participants-125551https://curecurrent.com/trials/digital-intervention-delivered-via-street-medicine-to-increase-hiv-and-substance-use-care-among-survivors-of-sex-traffic-125552https://curecurrent.com/trials/linking-youth-to-pre-exposure-prophylaxis-prep-services-125553https://curecurrent.com/trials/effects-of-ly3848575-versus-placebo-in-participants-with-painful-distal-sensory-polyneuropathy-125554https://curecurrent.com/trials/delivery-optimization-for-pre-exposure-prophylaxis-do-prep-study-125555https://curecurrent.com/trials/clinical-trials-to-evaluate-metformin-to-treat-depression-in-people-living-with-hiv-125556https://curecurrent.com/trials/harm-reduction-in-hiv-primary-care-for-plwh-who-use-drugs-125557https://curecurrent.com/trials/patient-provider-decision-aid-for-hiv-post-exposure-prophylaxis-following-sexual-assault-125558https://curecurrent.com/trials/start-the-conversation-evaluating-implementation-of-a-multi-level-prep-initiative-for-black-cisgender-women-in-nola-125559https://curecurrent.com/trials/intervening-with-haitian-immigrants-in-the-u-s-to-improve-hiv-outcomes-125560https://curecurrent.com/trials/immune-cell-therapy-car-t-for-the-treatment-of-patients-with-hiv-and-b-cell-non-hodgkin-lymphoma-125561https://curecurrent.com/trials/weexpand-prep-demonstration-project-among-women-at-risk-for-hiv-infection-preexposure-prophylaxis-prep-125562https://curecurrent.com/trials/evaluating-the-pharmacokinetics-safety-and-tolerability-of-bedaquiline-in-infants-children-and-adolescents-with-multidru-125563https://curecurrent.com/trials/a-study-to-evaluate-efficacy-safety-and-tolerability-in-antiretroviral-therapy-art-experienced-participants-of-at-least-125564https://curecurrent.com/trials/long-acting-hiv-pre-exposure-prophylaxis-integrated-with-sexual-and-reproductive-health-crct-125565https://curecurrent.com/trials/biomarkers-for-post-treatment-control-in-hiv-international-study-of-the-eu2cure-research-consortium-phase-i-125566https://curecurrent.com/trials/study-of-combined-garp-tgf-1-pd-1-blockade-as-a-shock-and-kill-strategy-in-hiv-1-cure-125567https://curecurrent.com/trials/study-of-hiv-exposed-pregnancies-and-transplacental-antibody-delivery-following-rsvpref-125568https://curecurrent.com/trials/development-of-a-multilevel-hiv-prevention-intervention-for-the-emergency-department-125569https://curecurrent.com/trials/sexual-health-advocacy-for-guys-a-text-messaging-based-hiv-prevention-program-for-guys-who-are-into-guys-125570https://curecurrent.com/trials/pol-and-access-intervention-to-reduce-hiv-stigma-among-service-providers-in-china-125571https://curecurrent.com/trials/pediatric-hiv-disclosure-benefits-study-phd-bs-sankofa-2-125572https://curecurrent.com/trials/effectiveness-and-implementation-of-text-messaging-to-improve-hiv-testing-in-adolescents-125573https://curecurrent.com/trials/doravirine-dor-in-human-immunodeficiency-virus-hiv-infected-children-aged-4-weeks-to-12-years-and-45-kg-mk-1439-066-125574https://curecurrent.com/trials/trial-to-evaluate-the-safety-and-immunogenicity-of-priming-regimens-of-426c-mod-core-c4b-and-optional-boost-regimen-with-125575https://curecurrent.com/trials/lenacapavir-intensification-to-disrupt-hiv-reservoirs-in-virologically-suppressed-people-with-hiv-receiving-antiretrovir-125576https://curecurrent.com/trials/study-of-bepirovirsen-in-participants-living-with-human-immunodeficiency-virus-and-chronic-hepatitis-b-virus-infection-b-125577https://curecurrent.com/trials/study-evaluating-the-efficacy-safety-and-tolerability-of-switching-to-long-acting-cabotegravir-plus-long-acting-rilpivir-125578https://curecurrent.com/trials/vgx-3100-and-electroporation-in-treating-patients-with-hiv-positive-high-grade-anal-lesions-125579https://curecurrent.com/trials/effects-of-tens-and-mindfulness-meditation-in-persons-with-hiv-related-neuropathy-125580https://curecurrent.com/trials/clofazimine-and-rifapentine-containing-treatment-shortening-regimens-in-drug-susceptible-tuberculosis-the-clo-fast-study-125581https://curecurrent.com/trials/impact-of-migration-history-and-social-conditions-on-the-immuno-virological-control-of-hiv-in-migrants-in-france-125582https://curecurrent.com/trials/anal-cytology-collection-procedures-in-predicting-high-grade-anal-dysplasia-in-men-who-have-sex-with-men-125583https://curecurrent.com/trials/pilot-study-to-evaluate-efficacy-and-safety-of-switching-to-bic-ftc-taf-in-pwh-with-a-previous-virological-failure-under-125584https://curecurrent.com/trials/risk-of-morbidity-mortality-and-long-term-monitoring-of-antiretroviral-treatment-in-people-living-with-hiv-125585https://curecurrent.com/trials/pep-prep-via-pharmacist-prescribing-implementation-peppi-125586https://curecurrent.com/trials/healthy-behaviors-for-insomnia-prevention-in-people-with-hiv-and-ongoing-pain-125587https://curecurrent.com/trials/screening-study-for-cervical-pre-cancer-and-cancer-prevention-in-south-african-women-125588https://curecurrent.com/trials/combination-vaccination-and-broadly-neutralising-antibody-therapy-in-hiv-125589https://curecurrent.com/trials/characterization-of-vaccine-induced-responses-against-monkeypox-movihvax-an-observational-prospective-cohort-study-125590https://curecurrent.com/trials/study-of-the-safety-and-efficacy-of-the-subunit-recombinant-tuberculosis-vaccine-gamtbvac-125591https://curecurrent.com/trials/thetha-nami-ngithethe-nawe-let-s-talk-step-wedge-crct-of-peer-led-community-prep-and-srh-for-youth-in-south-africa-125592https://curecurrent.com/trials/safety-and-impact-of-baricitinib-on-cell-surivival-pathways-hiv-1-reservoir-and-inflamation-in-people-with-hiv-1-125593https://curecurrent.com/trials/change-my-story-task-shifted-mental-health-intervention-125594https://curecurrent.com/trials/supporting-sustained-hiv-treatment-adherence-after-initiation-125595https://curecurrent.com/trials/a-stigma-reduction-intervention-at-time-of-entry-into-antenatal-care-to-improve-pmtct-services-in-tanzania-125596https://curecurrent.com/trials/safe-spaces-4-sexual-health-125597https://curecurrent.com/trials/scaling-up-implementation-strategies-to-improve-the-diagnose-and-prevent-pillars-for-young-msm-in-florida-125598https://curecurrent.com/trials/an-ai-based-mhealth-intervention-to-improve-hiv-testing-125599https://curecurrent.com/trials/establishing-optimal-number-of-doses-for-hpv-vaccination-in-children-and-adolescents-living-with-hiv-optimo-trial-125600https://curecurrent.com/trials/mentor-moms-study-125601https://curecurrent.com/trials/the-microvascular-brain-retina-and-kidney-study-125602https://curecurrent.com/trials/smoking-stress-hiv-and-mobile-technology-125603https://curecurrent.com/trials/mass-balance-and-absolute-oral-bioavailability-of-14c-vh4524184-125604https://curecurrent.com/trials/transcendenthealth-a-text-messaging-pregnancy-prevention-program-for-transgender-boys-125605https://curecurrent.com/trials/liver-fibrosis-in-zambian-hiv-hbv-co-infected-patients-125606https://curecurrent.com/trials/a-study-to-learn-about-the-vaccine-rsvpref-in-pregnant-participants-with-hiv-and-their-infants-125607https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-safety-and-tolerability-of-using-an-oral-once-daily-2-drug-regimen-compared-to-an-oral-125608https://curecurrent.com/trials/mitigating-infectious-morbidity-and-growth-deficits-in-hiv-exposed-uninfected-infants-with-human-milk-oligosaccharides-125609https://curecurrent.com/trials/gabapentin-to-reduce-alcohol-and-improve-viral-load-suppression-125610https://curecurrent.com/trials/safety-and-immunogenicity-study-of-three-mrnas-encoding-hiv-immunogens-in-adult-participants-without-hiv-and-in-overall-125611https://curecurrent.com/trials/an-acceptance-based-prep-intervention-to-engage-young-black-msm-in-the-south-125612https://curecurrent.com/trials/effectiveness-and-safety-of-darunavir-cobicistat-plus-lamivudine-compared-with-darunavir-cobicistat-plus-tenofovir-alafe-125613https://curecurrent.com/trials/leveraging-project-echo-for-improved-cervical-cancer-screening-in-ethiopia-125614https://curecurrent.com/trials/home-based-self-sampling-for-cervical-cancer-prevention-education-intervention-in-ghana-125615https://curecurrent.com/trials/common-elements-treatment-approach-hiv-alcohol-reduction-trial-in-zambia-125616https://curecurrent.com/trials/texting-to-reduce-human-immunodeficiency-virus-hiv-risk-125617https://curecurrent.com/trials/simplified-model-of-linkage-and-retention-to-care-using-a-mobile-unit-and-a-same-day-test-and-treat-approach-among-exclu-125618https://curecurrent.com/trials/adapt-for-adolescents-adolescents-125619https://curecurrent.com/trials/a-study-to-assess-the-safety-and-pharmacokinetics-of-a-human-monoclonal-antibody-vh4527079-in-healthy-adults-and-persons-125620https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-polyvalent-dna-and-recombinant-gp120-protein-hiv-vaccine-pdphv-in-healthy-hi-125621https://curecurrent.com/trials/immediate-art-in-subjects-with-opportunistic-diseases-125622https://curecurrent.com/trials/promoting-viral-suppression-among-transgender-women-living-with-hiv-in-santo-domingo-125623https://curecurrent.com/trials/integrating-project-yes-with-who-endorsed-mental-health-approaches-among-youth-living-with-hiv-125624https://curecurrent.com/trials/implementation-of-sttr-strategies-among-people-who-inject-drugs-in-malaysia-125625https://curecurrent.com/trials/tobacco-cessation-texting-intervention-for-people-living-with-hiv-who-smoke-in-vietnam-125626https://curecurrent.com/trials/the-neural-underpinnings-of-depression-and-cannabis-use-in-young-people-living-with-hiv-125627https://curecurrent.com/trials/examining-migration-social-bonds-transnationalism-and-hiv-prevention-pathways-among-african-immigrants-125628https://curecurrent.com/trials/hiv-antigen-specific-t-cells-targeting-conserved-epitopes-hst-neets-bmtctn1903-125629https://curecurrent.com/trials/integrated-navigation-services-for-treatment-adherence-counseling-and-research-125630https://curecurrent.com/trials/nice-human-immunodeficiency-virus-hiv-cohort-125631https://curecurrent.com/trials/effects-of-a-package-of-evidence-based-interventions-and-implementation-strategies-based-on-who-pen-for-people-living-wi-125632https://curecurrent.com/trials/clinical-study-to-evaluate-siipl-qhpv-vaccine-cervavac-in-women-living-with-hiv-aged-15-25-years-125633https://curecurrent.com/trials/impact-of-a-telenovela-soap-opera-for-hiv-prevention-in-latinas-125634https://curecurrent.com/trials/practice-facilitation-as-a-strategy-to-improve-alcohol-treatment-adoption-and-implementation-in-hiv-care-125635https://curecurrent.com/trials/mypeeps-mobile-plus-a-multi-level-hiv-prevention-intervention-for-young-msm-125636https://curecurrent.com/trials/addressing-psychosocial-comorbidities-in-hiv-treatment-and-prevention-2b-125637https://curecurrent.com/trials/the-comprehensive-adherence-resource-and-empowerment-support-cares-study-125638https://curecurrent.com/trials/a-technology-based-psychosocial-intervention-to-support-social-engagement-and-well-being-in-older-adults-with-hiv-125639https://curecurrent.com/trials/optimization-of-cervical-cancer-screening-among-women-living-with-hiv-in-latin-american-countries-125640https://curecurrent.com/trials/an-mhealth-intervention-to-improve-hiv-prevention-service-engagement-among-people-who-use-drugs-125641https://curecurrent.com/trials/pilot-testing-into-the-feasibility-of-the-developed-cognitive-behavioral-therapy-intervention-125642https://curecurrent.com/trials/cervical-pre-cancer-treatment-failure-among-women-living-with-hiv-in-zimbabwe-125643https://curecurrent.com/trials/evaluating-the-pharmacokinetics-safety-and-tolerability-of-delamanid-in-combination-with-optimized-multidrug-background-125644https://curecurrent.com/trials/rifapentine-based-shorter-regimens-for-tuberculosis-and-tb-infection-in-kazakhstan-125645https://curecurrent.com/trials/dental-management-of-patients-with-hiv-in-pays-de-la-loire-125646https://curecurrent.com/trials/safety-and-efficacy-of-b-f-taf-in-pregnancy-125647https://curecurrent.com/trials/hiv-antibody-increases-following-viral-rebound-in-people-receiving-antiretroviral-therapy-125648https://curecurrent.com/trials/testing-the-integrated-mhealth-app-intervention-sis-h-125649https://curecurrent.com/trials/skin-muscle-and-bone-aging-determinants-in-hiv-infected-patients-125650https://curecurrent.com/trials/intensified-tuberculosis-treatment-to-reduce-the-mortality-of-patients-with-tuberculous-meningitis-125651https://curecurrent.com/trials/bridges-an-hiv-doula-program-125652https://curecurrent.com/trials/coronary-artery-calcium-score-in-hiv-mexican-population-the-cacshivmex-study-125653https://curecurrent.com/trials/mobile-health-intervention-to-increase-hiv-testing-and-linkage-to-care-125654https://curecurrent.com/trials/robotic-bronchoscopy-with-cbct-image-fusion-for-pulmonary-nodule-diagnosis-in-people-living-with-hiv-125655https://curecurrent.com/trials/estep-an-integrated-mhealth-intervention-to-engage-high-risk-individuals-along-the-full-prep-care-continuum-125656https://curecurrent.com/trials/mitigating-the-impact-of-stigma-and-shame-among-people-living-with-hiv-and-substance-use-disorders-125657https://curecurrent.com/trials/evaluating-an-interactive-digital-toolkit-for-women-s-prep-implementation-125658https://curecurrent.com/trials/duo-a-phase-iiib-individual-level-randomized-controlled-trial-of-an-integrated-strategy-125659https://curecurrent.com/trials/relationship-of-exercise-sleep-and-inflammation-markers-in-people-living-with-hiv-125660https://curecurrent.com/trials/comparison-of-inflammatory-markers-and-incidence-of-comorbidities-in-patients-on-antiretroviral-therapy-with-second-gene-125661https://curecurrent.com/trials/an-effectiveness-trial-of-the-prep-for-wings-study-125662https://curecurrent.com/trials/pilot-of-an-intervention-to-reduce-alcohol-use-and-improve-art-adherence-among-men-living-with-hiv-with-pregnant-partner-125663https://curecurrent.com/trials/zambian-informed-motivated-aware-responsible-adolescent-girls-and-adults-125664https://curecurrent.com/trials/mk-4646-multiple-dose-trial-in-participants-with-human-immunodeficiency-virus-type-1-hiv-1-mk-4646-003-125665https://curecurrent.com/trials/buprenorphine-group-medical-visits-in-primary-care-125666https://curecurrent.com/trials/kidney-transplantation-from-donors-with-hiv-impact-on-rejection-and-long-term-outcomes-expanding-hope-kidney-125667https://curecurrent.com/trials/developing-and-testing-a-digital-health-tool-for-intersectional-stigma-assessment-and-reduction-at-multiple-levels-and-m-125668https://curecurrent.com/trials/the-women-taf-ftc-benchmark-study-125669https://curecurrent.com/trials/hiv-testing-counselor-led-care-to-catalyze-integration-of-prep-delivery-in-family-planning-clinics-125670https://curecurrent.com/trials/intestinal-tissue-resident-memory-t-cells-and-hiv-1-persistence-during-antiretroviral-therapy-125671https://curecurrent.com/trials/project-phakama-testing-support-strategies-to-empower-young-women-on-prep-in-south-africa-125672https://curecurrent.com/trials/impact-of-raltegravir-on-the-viral-reservoirs-125673https://curecurrent.com/trials/comparison-of-acceptance-and-commitment-therapy-and-cognitive-behavior-therapy-managing-psychological-distress-and-its-m-125674https://curecurrent.com/trials/behavioral-activation-and-risk-reduction-for-stimulant-use-among-sexually-active-adolescents-and-young-adults-125675https://curecurrent.com/trials/off-label-medications-for-alcohol-use-disorder-among-patients-with-hiv-pilot-study-1-125676https://curecurrent.com/trials/optimizing-implementation-of-long-acting-injectable-prep-125677https://curecurrent.com/trials/evaluation-of-a-multi-component-intervention-to-support-hiv-testing-and-linkage-to-services-among-msm-in-peru-125678https://curecurrent.com/trials/pneumocystis-pneumonia-diagnosis-in-hiv-patients-125679https://curecurrent.com/trials/optimizing-evidence-based-hiv-prevention-targeting-people-who-inject-drugs-on-prep-125680https://curecurrent.com/trials/pilot-study-on-once-daily-ftc-ddi-efavirenz-combination-in-antiretroviral-naive-hiv-infected-adults-125681https://curecurrent.com/trials/alcohol-reduction-among-people-with-tb-and-hiv-in-india-125682https://curecurrent.com/trials/antibody-responses-to-pneumococcal-vaccines-among-hiv-infected-adults-125683https://curecurrent.com/trials/restore-study-r61-phase-recovery-and-engagement-for-stimulant-users-on-re-entry-125684https://curecurrent.com/trials/social-media-hiv-prevention-intervention-for-high-risk-rural-women-125685https://curecurrent.com/trials/salvage-therapy-with-amprenavir-lopinavir-and-ritonavir-in-hiv-infected-patients-in-virological-failure-125686https://curecurrent.com/trials/the-women-tdf-ftc-benchmark-study-125687https://curecurrent.com/trials/covid-19-serology-and-immunosenescence-125688https://curecurrent.com/trials/liver-transplantation-in-patients-with-hepatitis-c-virus-hcv-and-human-immunodeficiency-virus-hiv-coinfection-125689https://curecurrent.com/trials/once-daily-antiretroviral-therapy-in-hiv-infected-adults-treated-with-haart-125690https://curecurrent.com/trials/integrated-hiv-prevention-and-hcv-care-for-pwid-125691https://curecurrent.com/trials/study-of-lenacapavir-taken-twice-a-year-for-hiv-pre-exposure-prophylaxis-prep-125692https://curecurrent.com/trials/open-trial-of-trauma-focused-psychodynamic-psychotherapy-for-people-living-with-hiv-and-ptsd-125693https://curecurrent.com/trials/multimorbidity-and-polypharmacy-in-people-with-hiv-vs-the-general-population-in-the-basque-country-125694https://curecurrent.com/trials/integrated-online-to-offline-o2o-model-of-care-for-hiv-prevention-and-treatment-among-men-who-have-sex-with-men-125695https://curecurrent.com/trials/integrated-online-to-offline-o2o-model-of-care-for-hiv-prevention-and-treatment-among-transgender-women-cintai-125696https://curecurrent.com/trials/impacts-of-hiv-treatment-regimens-on-archived-drug-resistance-125697https://curecurrent.com/trials/analytic-treatment-interruption-ati-to-assess-hiv-cure-125698https://curecurrent.com/trials/immunogenicity-of-mf59-adjuvanted-versus-high-dose-influenza-vaccine-in-people-with-hiv-a-randomized-clinical-trial-125699https://curecurrent.com/trials/to-evaluate-the-safety-of-jl18008-125700https://curecurrent.com/trials/prevalence-of-thyroid-function-abnormalities-in-hiv-infected-patients-125701https://curecurrent.com/trials/lafiya-hiv-self-testing-study-protocol-125702https://curecurrent.com/trials/clinic-community-bridge-to-improve-health-outcomes-for-abused-women-living-with-hiv-aids-125703https://curecurrent.com/trials/evaluation-of-the-safety-and-the-tolerability-of-a-combination-of-two-hiv-inducers-in-patients-with-undetectable-viral-l-125704https://curecurrent.com/trials/lafiya-hiv-status-neutral-study-protocol-125705https://curecurrent.com/trials/inflammation-in-methamphetamine-and-stis-imsti-125706https://curecurrent.com/trials/share-program-sustain-125707https://curecurrent.com/trials/long-acting-cabotegravir-and-rilpivirine-in-people-living-with-hiv-1-subtype-a6-a-real-world-retrospective-study-125708https://curecurrent.com/trials/boosting-olfactory-and-sensory-training-study-boost-125709https://curecurrent.com/trials/sti-testing-to-enhance-prep-use-in-pregnancy-125710https://curecurrent.com/trials/male-partner-engagement-in-hiv-testing-using-partner-notification-slip-plus-oral-hiv-self-testing-kit-125711https://curecurrent.com/trials/lipidomic-and-multi-omics-profiling-of-fatty-liver-disease-in-people-with-and-without-hiv-125712https://curecurrent.com/trials/resistance-profile-to-antiretroviral-medications-in-individuals-living-with-hiv-who-failed-a-first-line-regimen-with-ten-125713https://curecurrent.com/trials/healthy-choices-to-reduce-stigma-and-improve-self-management-of-alcohol-and-hiv-among-young-adults-125714https://curecurrent.com/trials/integra-a-vanguard-study-of-health-service-delivery-in-a-mobile-health-delivery-unit-125715https://curecurrent.com/trials/adolescents-living-with-hiv-alwh-social-networks-adherence-and-retention-125716https://curecurrent.com/trials/tmc125-tidp35-c239-continued-access-to-etravirine-etr-in-treatment-experienced-hiv-1-infected-participants-125717https://curecurrent.com/trials/prescribe-to-prevent-hiv-a-hybrid-trial-helping-addiction-clinics-prevent-hiv-infections-through-safer-drug-use-support-125718https://curecurrent.com/trials/naltrexone-for-overdose-prevention-125719https://curecurrent.com/trials/e-cigarette-harm-reduction-among-plwha-in-south-africa-125720https://curecurrent.com/trials/a-clinical-study-evaluating-the-safety-tolerability-and-effect-on-hiv-reservoir-of-ibalizumab-combined-with-chidamide-a-125721https://curecurrent.com/trials/streamlined-treatment-and-evidence-based-adolescent-counseling-and-medication-support-streams-125722https://curecurrent.com/trials/guaranteed-income-to-boost-hiv-care-continuity-and-suppression-post-jail-release-125723https://curecurrent.com/trials/post-injectable-cabotegravir-antiretroviral-salvage-strategy-options-trial-125724https://curecurrent.com/trials/integrating-a-stepped-care-model-of-screening-and-treatment-for-depression-into-malawi-s-national-hiv-care-delivery-plat-125725https://curecurrent.com/trials/evaluating-smoking-cessation-interventions-for-pwh-in-south-africa-125726https://curecurrent.com/trials/a-prophylactic-hiv-vaccine-trial-to-evaluate-the-safety-and-immunogenicity-of-hiv-clade-c-drep-alone-and-in-combination-125727https://curecurrent.com/trials/skeletal-muscle-energetics-and-fatiguability-in-older-individuals-125728https://curecurrent.com/trials/reducing-antiretroviral-treatments-125729https://curecurrent.com/trials/simunye-a-couples-focused-intervention-for-hiv-prevention-and-care-in-south-africa-125730https://curecurrent.com/trials/comparative-trial-between-ainuovirine-anv-lamivudine-3tc-tenofovir-tdf-and-efavirenz-efv-lamivudine-tenofovir-regimens-125731https://curecurrent.com/trials/evaluation-of-multiple-interventions-to-improve-hiv-treatment-outcomes-among-people-who-inject-drugs-in-india-125732https://curecurrent.com/trials/improving-the-hiv-care-continuum-with-mhealth-technology-125733https://curecurrent.com/trials/suicide-assessment-and-feasible-evidence-based-treatments-for-youth-living-with-hiv-in-lilongwe-125734https://curecurrent.com/trials/feasibility-of-internet-based-hiv-prevention-research-125735https://curecurrent.com/trials/protect-and-improve-cluster-of-differentiation-4-cd4-cells-and-b-cells-lymphocytes-125736https://curecurrent.com/trials/gut-microbiota-mediated-inflammatory-interactions-between-aud-and-hiv-infection-125737https://curecurrent.com/trials/midwest-txtxt-scale-up-of-an-evidence-based-intervention-to-promote-hiv-medication-adherence-125738https://curecurrent.com/trials/screening-and-follow-up-in-patients-with-hiv-infection-combined-with-metabolic-associated-fatty-liver-disease-125739https://curecurrent.com/trials/improving-clinic-delivery-of-hiv-related-anal-health-services-125740https://curecurrent.com/trials/testing-the-efficacy-of-safe-south-africa-125741https://curecurrent.com/trials/assessing-the-feasibility-of-hairdressers-as-sexual-health-champions-125742https://curecurrent.com/trials/a-self-administered-prep-decisional-aid-for-dissemination-with-hiv-self-test-kits-dash-125743https://curecurrent.com/trials/integrated-e-health-electronic-health-for-hiv-and-substance-use-disorders-in-justice-involved-women-125744https://curecurrent.com/trials/study-of-doravirine-islatravir-dor-isl-100-mg-0-75-mg-to-evaluate-the-antiretroviral-activity-safety-and-tolerability-in-125745https://curecurrent.com/trials/alternative-viral-load-tests-during-start-of-antiretroviral-therapy-125746https://curecurrent.com/trials/community-based-education-navigation-and-support-intervention-for-military-veterans-125747https://curecurrent.com/trials/integrating-isyv-within-hiv-clinical-care-for-youth-living-with-hiv-in-tanzania-125748https://curecurrent.com/trials/reduce-tobacco-use-in-people-living-with-hiv-in-switzerland-125749https://curecurrent.com/trials/structured-peer-delivered-art-and-reentry-community-strategy-125750https://curecurrent.com/trials/10e8-4-imab-bispecific-antibody-and-vrc07-523ls-monoclonal-antibody-in-hiv-infected-adults-125751https://curecurrent.com/trials/nutrition-to-optimize-understand-and-restore-insulin-sensitivity-in-hiv-for-oklahoma-125752https://curecurrent.com/trials/incidence-of-liver-disease-related-outcomes-in-people-with-hiv-125753https://curecurrent.com/trials/income-generation-food-and-nutrient-security-for-improved-livelihoods-and-health-outcomes-among-hiv-positive-kenya-125754https://curecurrent.com/trials/twyshe-an-mhealth-peer-navigator-intervention-to-increase-prep-and-contraceptive-use-125755https://curecurrent.com/trials/hiv-pre-exposure-prophylaxis-prep-linkage-with-immediate-medications-in-the-emergency-department-study-125756https://curecurrent.com/trials/pravastatin-and-protease-inhibitors-in-hiv-infected-patients-125757https://curecurrent.com/trials/implementing-tobacco-use-treatment-in-hiv-clinics-vietnam-125758https://curecurrent.com/trials/hiv-drug-resistance-among-individuals-failing-tenofovir-lamivudine-and-dolutegravir-first-line-regimen-in-brazil-125759https://curecurrent.com/trials/a-study-of-daratumumab-and-dose-adjusted-epoch-in-plasmablastic-lymphoma-125760https://curecurrent.com/trials/personalized-normative-feedback-to-increase-hiv-testing-125761https://curecurrent.com/trials/clinical-trial-of-gammora-plus-antiretroviral-treatment-for-hiv-125762https://curecurrent.com/trials/steroids-and-enhanced-spectrum-antibiotics-for-the-treatment-of-patients-in-africa-with-refractory-sepsis-125763https://curecurrent.com/trials/question-order-effect-experiment-to-measure-hiv-stigma-125764https://curecurrent.com/trials/collecting-blood-and-tissue-sample-donations-for-research-for-hiv-aids-related-cancers-125765https://curecurrent.com/trials/initiative-for-chinese-sex-workers-to-promote-wellbeing-and-improve-hiv-prevention-by-reducing-intersectional-stigma-125766https://curecurrent.com/trials/baps-in-botswana-the-thotloetso-trial-125767https://curecurrent.com/trials/the-targeted-neurocognitive-training-tnt-study-125768https://curecurrent.com/trials/task-shifting-to-treat-depression-and-hiv-medication-nonadherence-in-low-resource-settings-125769https://curecurrent.com/trials/study-of-neurological-aging-among-people-living-with-hiv-125770https://curecurrent.com/trials/study-to-evaluate-pharmacokinetic-pk-safety-and-tolerability-of-cabotegravir-cab-400-milligrams-per-milliliter-mg-ml-for-125771https://curecurrent.com/trials/testing-the-wecare-intervention-to-address-mental-health-and-medication-adherence-challenges-among-msm-in-south-africa-125772https://curecurrent.com/trials/bridges2scale-testing-implementation-strategies-125773https://curecurrent.com/trials/safety-immunogenicity-efficacy-of-ad26-mos4-hiv-mva-bn-hiv-and-pgt121-pgdm1400-and-vrc07-523ls-in-hiv-1-infected-adults-125774https://curecurrent.com/trials/differentiated-service-delivery-for-pregnant-and-postpartum-women-living-with-hiv-and-their-infants-125775https://curecurrent.com/trials/an-adaptive-randomized-controlled-trial-125776https://curecurrent.com/trials/clinic-vs-clinic-community-outreach-hpv-self-collection-to-increase-cervical-screening-in-women-with-hiv-125777https://curecurrent.com/trials/the-effect-on-lipid-profile-of-switching-to-delstrigo-in-hiv-positive-patients-125778https://curecurrent.com/trials/high-intensity-exercise-to-attenuate-limitations-and-train-habits-in-older-adults-with-hiv-125779https://curecurrent.com/trials/influence-of-resentment-and-forgivingness-on-quality-of-life-in-people-living-with-hiv-125780https://curecurrent.com/trials/inflammation-and-depression-in-people-with-hiv-125781https://curecurrent.com/trials/protocol-rv-583-multinational-observational-cohort-of-hiv-and-other-infections-125782https://curecurrent.com/trials/study-of-limited-versus-continuous-isoniazid-tuberculosis-preventive-therapy-in-hiv-infected-persons-in-botswana-125783https://curecurrent.com/trials/a-study-to-evaluate-the-efficacy-safety-participant-choice-and-preference-of-an-oral-once-daily-regimen-or-a-long-acting-125784https://curecurrent.com/trials/short-course-regimens-for-ds-ptb-in-aids-patients-125785https://curecurrent.com/trials/advanced-hiv-disease-during-the-first-six-months-on-antiretroviral-therapy-in-zambia-125786https://curecurrent.com/trials/study-of-oral-tlr8-agonist-selgantolimod-on-hbsag-in-participants-with-both-chronic-hepatitis-b-and-hiv-125787https://curecurrent.com/trials/the-alama-project-autism-outcomes-and-neurobehavioral-markers-in-young-children-born-to-mothers-with-hiv-in-kenya-125788https://curecurrent.com/trials/glp-1-receptor-agonists-to-decrease-ethanol-and-cvd-risk-in-hiv-125789https://curecurrent.com/trials/closing-tb-gaps-for-people-living-with-hiv-tb-guidance-for-adaptable-patient-centered-service-125790https://curecurrent.com/trials/effectiveness-of-a-smoking-cessation-algorithm-integrated-into-hiv-primary-care-125791https://curecurrent.com/trials/a-study-of-the-safety-tolerability-and-pharmacokinetics-of-dolutegravir-in-neonates-exposed-to-hiv-1-125792https://curecurrent.com/trials/performance-of-clinical-metagenomics-in-stool-and-urine-samples-for-unexplained-diseases-diagnostic-and-emerging-disease-125793https://curecurrent.com/trials/functional-interval-training-for-veterans-exercising-through-telehealth-125794https://curecurrent.com/trials/menopausal-ht-for-women-living-with-hiv-hot-125795https://curecurrent.com/trials/orchid-an-online-intervention-for-persons-with-hiv-miami-125796https://curecurrent.com/trials/a-setting-focus-overdose-prevention-intervention-125797https://curecurrent.com/trials/brazilian-registry-of-chronic-non-communicable-diseases-in-people-living-with-hiv-aids-125798https://curecurrent.com/trials/group-based-intervention-to-improve-mental-health-and-adherence-among-youth-living-with-hiv-in-low-resource-settings-125799https://curecurrent.com/trials/multicenter-trial-evaluating-the-immunogenicity-of-hpv-vaccination-in-girls-on-immunosuppressive-therapy-125800https://curecurrent.com/trials/executive-functioning-training-study-125801https://curecurrent.com/trials/mobile-enhanced-prevention-support-for-people-leaving-jail-125802https://curecurrent.com/trials/health-information-for-infected-veterans-125803https://curecurrent.com/trials/a-spatial-analysis-of-hotspots-and-targeted-injection-settings-pilot-intervention-for-hiv-prevention-among-people-who-in-125804https://curecurrent.com/trials/mhealth-service-linkage-for-young-adults-impacted-by-the-criminal-legal-system-125805https://curecurrent.com/trials/3bnc117-ls-first-in-human-phase-1-study-125806https://curecurrent.com/trials/a-study-to-investigate-cabotegravir-for-neonates-exposed-to-hiv-1-125807https://curecurrent.com/trials/enhancing-the-organizational-social-context-to-improve-viral-suppression-and-retention-in-hiv-care-125808https://curecurrent.com/trials/gathering-online-for-dialogue-and-discussion-to-enhance-social-support-125809https://curecurrent.com/trials/a-peer-driven-intervention-to-increase-prep-uptake-among-minority-msm-125810https://curecurrent.com/trials/an-immunogenicity-and-safety-trial-of-mva-bn-in-adults-living-with-hiv-for-the-prevention-of-mpox-infection-in-kinshasa-125811https://curecurrent.com/trials/symptom-management-efficacy-study-to-reduce-distal-neuropathic-pain-125812https://curecurrent.com/trials/resilient-hiv-implementation-science-with-sgm-youths-using-evidence-125813https://curecurrent.com/trials/the-collaborative-care-prtner-study-125814https://curecurrent.com/trials/pre-exposure-prophylaxis-prep-adherence-for-black-msm-125815https://curecurrent.com/trials/gene-therapy-in-treating-patients-with-human-immunodeficiency-virus-related-lymphoma-receiving-stem-cell-transplant-125816https://curecurrent.com/trials/real-world-effectiveness-of-hpv-vaccine-in-women-living-with-hiv-and-its-impact-on-cervical-cancer-screening-accuracies-125817https://curecurrent.com/trials/implementation-trial-to-evaluate-a-population-health-combination-intervention-to-meet-hiv-testing-linkage-and-viral-supp-125818https://curecurrent.com/trials/improving-choice-and-use-of-biomedical-hiv-prevention-for-women-in-uganda-a-couples-based-approach-125819https://curecurrent.com/trials/treatment-of-chronic-hepatitis-c-with-peg-interferon-alfa2a-and-ribavirin-in-hiv-infected-patients-125820https://curecurrent.com/trials/study-to-evaluate-the-safety-tolerability-pharmacokinetics-and-immunogenicity-of-lp-98-injection-in-healthy-subjects-125821https://curecurrent.com/trials/pertussis-vaccination-among-hiv-infected-and-hiv-uninfected-pregnant-women-125822https://curecurrent.com/trials/hiv-self-testing-and-long-acting-injectables-for-hiv-treatment-and-prevention-among-commercial-minibus-drivers-i-test-la-125823https://curecurrent.com/trials/the-protect-prep-optimization-through-telehealth-care-and-treatment-trial-125824https://curecurrent.com/trials/hep-mec-cohort-in-zambia-125825https://curecurrent.com/trials/lopinavir-ritonavir-in-plwh-with-high-grade-ain-125826https://curecurrent.com/trials/developing-interventions-for-protecting-hiv-exposed-uninfected-infants-against-severe-infections-125827https://curecurrent.com/trials/substance-checking-outreach-and-pre-exposure-prophylaxis-prep-engagement-study-125828https://curecurrent.com/trials/an-economic-and-relationship-strengthening-intervention-to-reduce-alcohol-use-in-malawi-125829https://curecurrent.com/trials/feasibility-of-intravaginal-artesunate-as-adjuvant-hpv-cervical-precancer-treatment-in-kenya-125830https://curecurrent.com/trials/advancing-hpv-vaccination-among-hiv-positive-adults-the-champs-study-125831https://curecurrent.com/trials/assess-the-effectiveness-and-safety-of-lipovirtide-combined-with-nucleoside-drugs-in-hiv-infected-patients-125832https://curecurrent.com/trials/enhanced-treatment-strategy-for-disseminated-mac-infection-in-hiv-patients-a-randomized-controlled-trial-125833https://curecurrent.com/trials/assessing-the-use-of-my-ride-a-just-in-time-adaptive-intervention-to-improve-hiv-prevention-and-substance-use-in-youth-e-125834https://curecurrent.com/trials/improving-access-to-prep-hiv-prevention-medication-for-people-in-underserved-areas-of-rio-de-janeiro-125835https://curecurrent.com/trials/enhancing-prep-outcomes-among-kenyan-adolescent-girls-and-young-women-with-a-novel-pharmacy-based-prep-delivery-platform-125836https://curecurrent.com/trials/suubi-mhealth-a-mobile-health-intervention-to-address-depression-among-youth-125837https://curecurrent.com/trials/piloting-the-incentivized-text-based-adherence-game-intervention-125838https://curecurrent.com/trials/efficacy-and-safety-of-immune-checkpoint-inhibitors-for-refractory-opportunistic-infections-in-aids-125839https://curecurrent.com/trials/hybrid-type-1-effectiveness-implementation-trial-of-motivation-matters-125840https://curecurrent.com/trials/reducing-hazardous-alcohol-use-and-optimizing-treatment-as-prevention-among-men-living-with-hiv-in-risk-environments-125841https://curecurrent.com/trials/intervention-for-virologic-suppression-in-youth-125842https://curecurrent.com/trials/a-study-to-assess-the-safety-tolerability-and-pharmacokinetics-of-lipovirtide-in-hiv-infected-patients-125843https://curecurrent.com/trials/pharmacokinetics-and-efficacy-of-multiple-dosing-of-lipovirtide-for-injection-in-hiv-infected-patients-125844https://curecurrent.com/trials/the-coach-mpilo-study-evaluation-of-a-peer-led-intervention-to-promote-engagement-in-hiv-care-for-men-living-with-hiv-125845https://curecurrent.com/trials/exploratory-study-of-lp-98-for-injection-in-art-naive-hiv-infected-individuals-125846https://curecurrent.com/trials/telepharm-prep-pep-125847https://curecurrent.com/trials/adaptive-intervention-strategies-for-hiv-prep-care-in-rural-people-who-inject-drugs-125848https://curecurrent.com/trials/pharmacokinetics-and-efficacy-of-multiple-dosing-of-lp-98-for-injection-in-hiv-infected-patients-125849https://curecurrent.com/trials/evaluation-of-the-preventing-aids-through-live-movement-and-sound-palms-intervention-for-minority-adolescents-125850https://curecurrent.com/trials/a-safety-and-efficacy-trial-of-chidamide-combined-with-nkg2d-car-nk-cell-therapy-for-reducing-the-hiv-viral-reservoir-125851https://curecurrent.com/trials/effectiveness-of-relationship-education-for-reducing-hiv-incidence-among-men-who-have-sex-with-men-125852https://curecurrent.com/trials/testing-the-feasibility-of-different-hpv-screening-and-care-strategies-for-women-living-with-hiv-125853https://curecurrent.com/trials/topical-curcumin-for-hpv-related-cervical-disease-125854https://curecurrent.com/trials/evaluating-the-impact-of-computer-assisted-x-ray-diagnosis-and-other-triage-tools-to-optimise-xpert-orientated-community-125855https://curecurrent.com/trials/goals-for-adherence-with-low-cost-incentives-125856https://curecurrent.com/trials/prep-affect-regulation-treatment-innovation-125857https://curecurrent.com/trials/project-khanya-peer-delivered-intervention-to-improve-hiv-medication-adherence-and-substance-use-in-south-africa-125858https://curecurrent.com/trials/pomalidomide-as-an-immune-enhancing-agent-for-the-control-of-hiv-125859https://curecurrent.com/trials/inhibiting-the-anti-apoptotic-factor-bcl-2-at-the-time-of-art-initiation-to-promote-apoptosis-of-hiv-infected-cells-and-125860https://curecurrent.com/trials/prep-readiness-interventions-for-sustained-motivation-prism-125861https://curecurrent.com/trials/hepatitis-c-in-prison-study-of-screening-and-rapid-treatment-hepapris-125862https://curecurrent.com/trials/bcg-vaccination-effect-on-latent-reservoir-size-in-treated-hiv-1-infection-125863https://curecurrent.com/trials/hiv-patients-cohort-125864https://curecurrent.com/trials/project-to-enhance-patient-health-engagement-in-hiv-infection-125865https://curecurrent.com/trials/a-study-to-evaluate-the-performance-and-usability-of-truplex-hiv-hepb-syphilis-rapid-test-125866https://curecurrent.com/trials/integrated-mental-health-care-for-pregnant-women-with-hiv-in-kenya-the-tunawiri-study-125867https://curecurrent.com/trials/pre-and-post-treatment-lung-microbiota-metabolome-and-immune-signatures-at-the-site-of-disease-in-patients-with-active-p-125868https://curecurrent.com/trials/adherence-and-clinical-correlates-in-persons-with-hiv-on-taf-125869https://curecurrent.com/trials/virologic-and-immunologic-characteristics-of-severe-mpox-in-persons-with-advanced-hiv-125870https://curecurrent.com/trials/combining-social-network-strategies-and-routine-substance-use-screening-125871https://curecurrent.com/trials/the-impact-of-vaginal-washing-on-cervical-inflammation-125872https://curecurrent.com/trials/oral-islatravir-mk-8591-once-monthly-as-preexposure-prophylaxis-prep-in-men-and-transgender-women-who-are-at-high-risk-f-125873https://curecurrent.com/trials/uncpm-22314-pregnancy-infant-and-maternal-health-outcomes-study-125874https://curecurrent.com/trials/combating-related-epidemics-in-hcv-125875https://curecurrent.com/trials/the-impact-of-oral-health-in-hiv-patients-on-antiretroviral-therapy-125876https://curecurrent.com/trials/integrating-hiv-prevention-with-tb-household-contact-evaluation-in-uganda-125877https://curecurrent.com/trials/point-of-care-sti-testing-125878https://curecurrent.com/trials/pivotal-phase-2b-3-alvac-bivalent-gp120-mf59-hiv-vaccine-prevention-safety-and-efficacy-study-in-south-africa-125879https://curecurrent.com/trials/hepatitis-c-treatment-to-prevent-hiv-initiate-opioid-substitution-therapy-and-reduce-risky-behavior-125880https://curecurrent.com/trials/systems-analysis-and-improvement-approach-to-improve-integration-of-hiv-prevention-and-treatment-services-125881https://curecurrent.com/trials/cefixime-clinical-trial-125882https://curecurrent.com/trials/carmustine-etoposide-cyclophosphamide-and-stem-cell-transplant-in-treating-patients-with-hiv-associated-lymphoma-125883https://curecurrent.com/trials/therapeutic-drug-monitoring-for-linezolid-in-the-treatment-of-rifampin-resistant-tuberculosis-125884https://curecurrent.com/trials/dual-bnab-treatment-in-children-125885https://curecurrent.com/trials/the-prep-pre-exposure-prophylaxis-smart-study-125886https://curecurrent.com/trials/testing-a-self-management-intervention-in-hiv-asian-pacific-americans-125887https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-envseq-1-and-ch505-m5-gp120-envs-adjuvanted-with-gla-se-in-healthy-hiv-uninf-125888https://curecurrent.com/trials/prevention-of-aids-with-opportunistic-infection-paradoxical-iris-125889https://curecurrent.com/trials/innovative-administration-of-long-acting-injectables-for-hiv-treatment-enhancement-at-home-125890https://curecurrent.com/trials/improving-engagement-in-hiv-and-cancer-care-in-zimbabwe-125891https://curecurrent.com/trials/a-hybrid-type-ii-trial-of-the-optimizing-resilience-and-coping-with-hiv-through-internet-delivery-in-ryan-white-clinics-125892https://curecurrent.com/trials/effects-of-cannabidiol-and-tetrahydrocannabinol-on-microbiome-and-neuroinflammation-in-hiv-125893https://curecurrent.com/trials/mobile-health-mhealth-intervention-to-support-hiv-self-testing-and-prep-uptake-among-young-men-who-have-sex-with-men-125894https://curecurrent.com/trials/a-phase-2-trial-of-foscenvivint-in-liver-cirrhosis-patients-caused-by-hiv-hcv-co-infection-with-hemophilia-op-724-h201-125895https://curecurrent.com/trials/evaluating-inflammatory-and-immunological-changes-of-hiv-positive-patients-switching-to-dtg-dual-regimen-compared-to-tho-125896https://curecurrent.com/trials/cannabis-use-cognition-and-the-endocannabinoid-system-in-hiv-125897https://curecurrent.com/trials/client-centered-care-coordination-for-black-men-who-have-sex-with-men-125898https://curecurrent.com/trials/the-use-of-leukapheresis-to-support-hiv-pathogenesis-studies-125899https://curecurrent.com/trials/the-use-of-lymph-node-biopsies-to-support-hiv-pathogenesis-studies-125900https://curecurrent.com/trials/exploratory-study-on-the-treatment-of-eb-virus-positive-hiv-associated-lymphoma-with-ebv-mrna-vaccine-125901https://curecurrent.com/trials/screening-for-anal-cancer-in-men-who-have-sex-with-men-using-pre-exposure-prophylaxis-125902https://curecurrent.com/trials/women-focused-encounters-for-resilience-independence-strength-and-eudaimonia-125903https://curecurrent.com/trials/medical-mistrust-among-hispanic-latino-gay-bisexual-and-other-men-who-have-sex-with-men-hlmsm-125904https://curecurrent.com/trials/beyond-study-improving-hiv-treatment-and-well-being-among-young-msm-in-vietnam-125905https://curecurrent.com/trials/assessing-performance-of-a-hepatitis-c-emergency-department-hepc-end-screening-tool-it-integration-process-for-electroni-125906https://curecurrent.com/trials/comparing-immune-activation-and-latent-hiv-reservoir-size-between-people-living-with-hiv-on-tenofovir-containing-versus-125907https://curecurrent.com/trials/development-of-implementation-toolkits-125908https://curecurrent.com/trials/tell-me-more-dime-mas-125909https://curecurrent.com/trials/happy-homes-healthy-families-a-relationship-strengthening-intervention-for-pregnant-couples-affected-by-hiv-in-zambia-125910https://curecurrent.com/trials/enhanced-problem-solving-therapy-and-hiv-engagement-support-to-improve-perinatal-mental-health-hiv-outcomes-in-malawi-125911https://curecurrent.com/trials/hiv-hbv-hcv-triple-screening-in-primary-care-125912https://curecurrent.com/trials/development-of-a-silica-microparticle-taggant-system-to-measure-art-adherence-125913https://curecurrent.com/trials/leveraging-pharmacy-technicians-to-advance-the-reach-of-modern-antiretroviral-therapy-pharm-art-in-community-clinics-125914https://curecurrent.com/trials/sistas-informing-sistas-on-topics-about-aids-and-prevention-sista-p-125915https://curecurrent.com/trials/a-cohort-study-of-use-of-doravirine-dor-based-regimens-in-clinical-practice-in-europe-doravirine-europe-real-world-125916https://curecurrent.com/trials/characteristics-of-immunity-in-gut-mucosa-spinal-fluid-lymph-node-and-blood-of-hiv-negative-thais-and-thais-with-hiv-inf-125917https://curecurrent.com/trials/increasing-hiv-sti-home-testing-via-a-digital-intervention-among-black-women-125918https://curecurrent.com/trials/post-analytic-treatment-interruption-study-125919https://curecurrent.com/trials/immunogenicity-and-safety-of-recombinant-zoster-vaccine-in-people-living-with-hiv-125920https://curecurrent.com/trials/the-test-to-prep-study-125921https://curecurrent.com/trials/establish-and-characterize-an-acute-hiv-infection-cohort-in-a-high-risk-population-125922https://curecurrent.com/trials/stress-and-pain-in-people-living-with-hiv-125923https://curecurrent.com/trials/integrated-care-versus-usual-care-for-opioid-use-disorder-and-infectious-diseases-in-veterans-125924https://curecurrent.com/trials/access-to-prep-for-msm-acceptability-and-feasibility-in-community-based-clinics-in-west-africa-cohmsm-prep-125925https://curecurrent.com/trials/ending-the-hiv-epidemic-through-point-of-care-technologies-ehpoc-125926https://curecurrent.com/trials/x-linked-biological-response-to-hiv-sensing-the-anrs-ep-53-study-125927https://curecurrent.com/trials/gut-associated-lymphocyte-trafficking-125928https://curecurrent.com/trials/a-clinical-trial-to-evaluate-safety-tolerability-and-immunogenicity-of-adjuvanted-hiv-1-fusion-peptide-conjugate-vaccine-125929https://curecurrent.com/trials/human-papillomavirus-infection-and-related-anal-lesions-in-hiv-positive-men-who-have-sex-with-men-125930https://curecurrent.com/trials/rct-of-an-intersectional-stigma-intervention-to-sustain-viral-suppression-among-women-living-with-serious-mental-illness-125931https://curecurrent.com/trials/residual-risk-assessment-of-hiv-transmission-125932https://curecurrent.com/trials/mobile-vehicle-based-delivery-of-lenacapavir-pre-exposure-prophylaxis-in-los-angeles-county-125933https://curecurrent.com/trials/residual-replication-of-hiv-1-in-the-gut-associated-lymphoid-tissue-galt-of-patients-on-highly-active-antiretroviral-the-125934https://curecurrent.com/trials/pilot-rct-and-interview-study-on-an-hiv-chatbot-in-nigeria-125935https://curecurrent.com/trials/assessment-of-metformin-for-restoration-of-immune-homeostasis-in-hiv-and-hiv-individuals-with-a-history-of-injection-dru-125936https://curecurrent.com/trials/the-synergistic-effects-of-menopause-and-hiv-on-cardiovascular-disease-risk-in-women-125937https://curecurrent.com/trials/peer-led-service-delivery-model-for-pregnant-and-lactating-adolescent-girls-and-young-women-in-zimbabwe-125938https://curecurrent.com/trials/prep-my-way-a-hybrid-type-1-clinical-effectiveness-implementation-trial-to-promote-prep-persistence-among-young-kenyan-w-125939https://curecurrent.com/trials/j-rise-relevant-implementation-strategies-to-eliminate-the-social-and-structural-barriers-to-hiv-services-among-justice-125940https://curecurrent.com/trials/efficacy-study-of-covid-19-mrna-vaccine-in-regions-with-sars-cov-2-variants-of-concern-125941https://curecurrent.com/trials/adaptation-and-implementation-of-an-evidence-based-approach-to-advance-hiv-prevention-and-care-125942https://curecurrent.com/trials/lower-intersecting-hiv-related-stigmas-to-facilitate-treatment-as-prevention-lift-125943https://curecurrent.com/trials/study-of-cobicistat-boosted-atazanavir-atv-co-cobicistat-boosted-darunavir-drv-co-and-emtricitabine-tenofovir-alafenamid-125944https://curecurrent.com/trials/trial-of-a-harm-reduction-strategy-for-people-with-hiv-who-smoke-cigarettes-125945https://curecurrent.com/trials/safety-and-immunogenicity-of-ad4-hiv-envelope-vaccine-vectors-in-healthy-volunteers-125946https://curecurrent.com/trials/intensive-combination-approach-to-rollback-the-epidemic-in-nigerian-adolescents-uh3-phase-125947https://curecurrent.com/trials/surgery-in-treating-patients-with-early-stage-anal-canal-or-perianal-cancer-and-hiv-infection-125948https://curecurrent.com/trials/telehealth-delivery-tele-b6-125949https://curecurrent.com/trials/clinical-trial-to-evaluate-the-safety-and-immunogenicity-of-ferritin-nanoparticles-expressing-native-like-hiv-1-envelope-125950https://curecurrent.com/trials/video-intervention-to-inspire-treatment-adherence-for-life-for-adolescents-125951https://curecurrent.com/trials/finishing-hiv-project-125952https://curecurrent.com/trials/omuyambi-traditional-healer-support-to-improve-hiv-viral-suppression-in-rural-uganda-125953https://curecurrent.com/trials/ending-the-hiv-epidemic-an-all-facility-intervention-for-patient-and-healthcare-staff-well-being-125954https://curecurrent.com/trials/act-for-hiv-positive-men-125955https://curecurrent.com/trials/a-latino-msm-focused-pre-exposure-prophylaxis-uptake-intervention-125956https://curecurrent.com/trials/working-memory-training-for-people-aging-with-hiv-125957https://curecurrent.com/trials/quality-of-life-depression-and-sexual-function-in-men-living-with-hiv-125958https://curecurrent.com/trials/imara-for-black-male-caregivers-and-girls-empowerment-image-125959https://curecurrent.com/trials/a-peer-led-intervention-to-improve-postpartum-retention-in-hiv-care-125960https://curecurrent.com/trials/single-dose-pharmacokinetics-of-doravirine-in-hiv-infected-pregnant-women-125961https://curecurrent.com/trials/off-label-medications-for-alcohol-use-disorder-among-patients-with-hiv-pilot-study-2-125962https://curecurrent.com/trials/study-on-pharmacokinetics-of-first-line-antiretrovirals-in-healthy-breastfeeding-volunteers-125963https://curecurrent.com/trials/a-study-of-mk-8527-in-healthy-lactating-female-participants-mk-8527-009-125964https://curecurrent.com/trials/zn-supplementation-in-hiv-immunological-non-responders-125965https://curecurrent.com/trials/golden-rice-cookies-with-piper-crocatum-for-blood-glucose-control-and-quality-of-life-in-people-living-with-hiv-with-hyp-125966https://curecurrent.com/trials/impact-of-immediate-versus-south-african-recommendations-guided-art-initiation-on-hiv-incidence-125967https://curecurrent.com/trials/feasibility-and-interest-of-a-hiv-quarterly-preventive-global-care-in-men-who-have-sex-with-men-in-sub-saharan-africa-125968https://curecurrent.com/trials/hiv-therapeutic-dna-vaccine-icvax-phase-i-clinical-trial-in-hong-kong-125969https://curecurrent.com/trials/hiv-prevention-and-care-engagement-in-nepal-125970https://curecurrent.com/trials/immunogenicity-and-safety-of-4-prime-boost-combinations-of-hiv-vaccine-candidates-in-healthy-volunteers-125971https://curecurrent.com/trials/paseo-intervention-for-adolescents-transitioning-to-adult-hiv-care-in-urban-peru-125972https://curecurrent.com/trials/evaluating-the-safety-and-immunogenicity-of-stabilized-ch505-tf-chtrimer-in-healthy-hiv-uninfected-adult-participants-125973https://curecurrent.com/trials/auditory-research-in-children-living-with-hiv-exposure-uninfected-archive-125974https://curecurrent.com/trials/the-gut-liver-and-metabolome-in-human-immunodeficiency-virus-and-non-alcoholic-fatty-liver-disease-125975https://curecurrent.com/trials/pomalidomide-in-treating-patients-with-kaposi-sarcoma-and-human-immunodeficiency-virus-infection-125976https://curecurrent.com/trials/b-f-taf-to-dtg-3tc-switch-study-125977https://curecurrent.com/trials/implementation-of-an-opt-out-testing-and-rapid-diagnostic-strategy-for-syphilis-and-hiv-in-pregnant-patients-presenting-125978https://curecurrent.com/trials/missed-opportunities-to-pre-exposure-prophylaxis-for-hiv-infection-on-person-newly-diagnosed-with-hiv-125979https://curecurrent.com/trials/renal-transplantation-and-raltegravir-in-hiv-infected-patients-125980https://curecurrent.com/trials/real-world-cohort-study-of-antiretroviral-therapy-in-hiv-patients-with-opportunistic-infections-125981https://curecurrent.com/trials/antiretroviral-treatment-taken-4-days-per-week-versus-continuous-therapy-7-7-days-per-week-in-hiv-1-infected-patients-125982https://curecurrent.com/trials/assessing-the-effects-of-a-multisectoral-agricultural-intervention-on-the-reproductive-and-sexual-health-of-adolescent-g-125983https://curecurrent.com/trials/kuwa-free-live-free-125984https://curecurrent.com/trials/collection-of-blood-for-multiple-collaborative-studies-125985https://curecurrent.com/trials/expanded-social-network-recruitment-to-hiv-testing-e-snrht-intervention-to-locate-undiagnosed-cases-and-reduce-hiv-relat-125986https://curecurrent.com/trials/weekly-doxycycline-dot-for-sti-prevention-among-cisgender-women-taking-hiv-prep-in-kisumu-kenya-125987https://curecurrent.com/trials/using-multiphase-optimization-strategy-most-to-optimize-a-cost-effective-sustainable-and-scalable-smoking-cessation-pack-125988https://curecurrent.com/trials/feasibility-and-limitations-of-offering-community-based-rapid-hiv-testing-to-men-who-have-sex-with-men-msm-125989https://curecurrent.com/trials/effect-of-methamphetamine-on-residual-latent-hiv-disease-study-125990https://curecurrent.com/trials/low-dose-naltrexone-for-pain-in-patients-with-hiv-125991https://curecurrent.com/trials/southern-sichuan-hiv-cohort-study-protocol-125992https://curecurrent.com/trials/ser-familia-a-family-based-intervention-addressing-syndemic-conditions-among-latino-immigrant-families-125993https://curecurrent.com/trials/enhancing-wellness-through-affirming-services-and-education-125994https://curecurrent.com/trials/car-t-cells-for-hiv-infection-125995https://curecurrent.com/trials/intensive-combination-approach-to-rollback-the-hiv-epidemic-in-nigerian-youth-icare-plus-effectiveness-implementation-hy-125996https://curecurrent.com/trials/efficacy-of-tenofovir-emtricitabine-and-efavirenz-in-hiv-infected-patients-with-tuberculosis-anrs129-125997https://curecurrent.com/trials/estradiol-therapy-in-transgender-women-to-research-interactions-with-hiv-therapy-125998https://curecurrent.com/trials/efficacy-of-adding-interleukin-2-to-an-optimized-antiretroviral-regimen-in-hiv-patients-in-therapeutic-failure-anrs123-125999https://curecurrent.com/trials/persuasive-health-communication-intervention-for-hiv-hcv-126000https://curecurrent.com/trials/using-technology-to-match-young-black-men-and-transwomen-who-have-sex-with-men-or-transwomen-to-hiv-testing-options-126001https://curecurrent.com/trials/evaluation-of-free-sti-testing-pilot-projects-in-lucerne-and-zurich-switzerland-126002https://curecurrent.com/trials/evaluation-of-a-new-strategy-to-approach-the-transgender-sex-worker-populations-and-their-clients-for-access-to-a-preven-126003https://curecurrent.com/trials/study-to-compare-the-immunogenicity-and-safety-of-two-hiv-preventive-vaccinations-in-healthy-volunteers-126004https://curecurrent.com/trials/integrating-sexual-pleasure-into-harm-reduction-services-for-men-who-have-sex-with-men-and-transgender-persons-who-engag-126005https://curecurrent.com/trials/hybrid-type-i-effectiveness-implementation-trial-of-a-social-network-support-intervention-126006https://curecurrent.com/trials/study-comparing-efficacy-and-safety-of-darunavir-boosted-with-ritonavir-to-hart-with-2-nrti-and-darunavir-boosted-with-r-126007